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Chapter 1 
 
General Introduction  
 
 
 10  
Of musculoskeletal disorders, knee complaints are the second most frequent reason (after spine 
related  pain) for consulting the general practitioner (1). Knee Osteoarthritis (OA) is a common 
chronic medical condition leading to progressive structural damage of the joints and subsequent 
functional disability (2). Until the age of 45 knee OA is rarely diagnosed and knee complaints are 
often related to(sports)injury and patellofemoral knee pain (1). In older adults, there is a 
significant increase of the incidence and prevalence of knee OA (incidence in the age groups of 45 
to 64 years, from 65 to 74 years and 75 years and older in men: 1.9, 4.1 and 7.3, respectively in 
women; 3.2 , 10.9 and 13.9 per 1000 people per year). Above the age of 74 years, the prevalence in 
men is 47.3  and 19.7  in women per 1,000 persons per year (1).  
Knee OA may develop after knee injury (3), whereas in other patients knee OA develops in a 
more generalized way without specific trauma, affecting multiple other joints. Known risk factors 
for the development of OA are mechanical forces including trauma, age, female gender, family 
history of OA, genetics, obesity, morphologic changes and OA localization in another joint (2;4-
9). To date no effective disease modifying medical therapy is available (10). 
Since OA is a disease affecting the elderly, studies investigating factors involved in OA 
development are usually performed in older populations with mean ages ranging from 50 to 80 
years (5;11-13). Determining which risk-factors of OA development can be distinguished early in 
life may help to define high-risk knee patients for the development of knee OA. This could be of 
clinical importance because high risk patients may benefit from slowing down or even stopping 
the OA process by early preventive exercise therapy or in the future to develop disease modifying 
medication, since to date no effective disease modifying medical therapy is available (10;14-16).  
To identify risk factors for OA early in life, we conducted a study to investigate knee function and 
knee OA development after 10 years in 326 patients (mean age 32, SD 7.7) with a history of sub-
acute knee complaints. Inclusion criteria 10 years ago were: persistent knee complaints e.g. pain, 
swelling and instability lasting for more than four weeks. Exclusion criteria were: knee complaints 
lasting less than four weeks, clinical symptoms of a locked knee, known inflammatory diseases 
such as rheumatoid arthritis, moderate to severe radiographic knee OA and a history of knee 
surgery. All patients were  part of a cohort of 855 knee patients who participated in a study on the 
cost-effectiveness of 0.5T magnetic resonance (MR) imaging relative to diagnostic arthroscopy 
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(17). The main objective of the study was to determine which prognostic factors for knee OA 
development could be identified in this relatively young population with a history of knee 
complaints. Identifying these specific prognostic factors may help to distinguish high-risk knee 
patients for the development of knee OA early in life, and to develop ways to slow down OA 
progression towards end stage disease. 
 
In Chapter 2 we investigated the role of  anterior cruciate ligament (ACL) and meniscal lesions 
and subsequent change in biomechanics of knee movement in the development of osteoarthritic 
changes visible on radiographs and MR imaging. Until recently, knee OA has been primarily 
visualized and assessed on radiographs by using the Kellgren and Lawrence (KL) scoring system 
(18). Investigators in large prospective studies have used radiographs with follow-up times of 10–
22 years to assess the effect of meniscal and anterior cruciate ligament (ACL) lesions on the 
development and progression of knee OA (19-22). Magnetic resonance (MR) imaging, owing to 
its ability to depict cartilage damage, subchondral bone, and bone marrow lesions, has however 
potential advantages in assessing the development of OA (23;24). Being a relatively new imaging 
modality, most MR imaging studies have been cross-sectional or have involved a maximal follow-
up time of only 3 years (25-28). Since no long-term MR studies were available, we wanted to 
determine the relationship between knee OA development detected on both radiographs and 3.0-
T MR images after 10 years and the presence of ACL ruptures or meniscal tears and the effect on 
OA development of surgical management of these lesions. The advantages of MR imaging could 
be useful in determining early OA changes in a relatively young study population. 
 
In Chapter 3 the accuracy and sensitivity to change in hand joint space width (JSW) 
measurements by a newly developed quantification method is investigated.  
Being a multi-factorial disease, relationships between knee OA development and the presence of 
OA in other joints, especially the hands have been described (29). Hand radiographs are used 
commonly to diagnose and monitor hand OA because of their wide availability and the relatively 
low costs. Since cartilage cannot be visualized by radiography, decrease of joint space width (JSW) 
is used as a surrogate marker for cartilage defects. Semi-quantitative methods with standard 
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atlases are the bench tools used by clinicians to determine changes in JSW (18;30). However, there 
is a limitation in reproducibility due to the difficulty to standardize the scoring between different 
readers. Since OA is a slowly progressive disease, an accurate and reproducible method is needed 
to detect subtle changes throughout follow-up, especially when evaluating new therapies. A newly 
developed JSW quantification method automatically detects the interphalangeal (IP) and 
metacarpophalangeal (MCP) joints and quantifies the JSW in hand radiographs (31). We assessed 
the accuracy and sensitivity to change in JSW of this quantification method by comparing the 
automatically determined JSW to the true distance between bony contours of the finger joints. 
Being able to detect small changes in JSW would make this method ideal for determining early 
OA changes in the hand and relate these changes to knee OA development in our relatively young 
study population. 
 
In Chapter 4 we investigated which of the following OA risk factors: ACL and /or meniscal 
lesions, age, female gender, body mass index (BMI), activity level before knee complaints, a family 
history of OA and the presence of hand OA could be related to OA development in our relatively 
young study population. Furthermore, subjective knee function 10 years after knee complaints 
was determined in relation to osteoarthritic changes, age, gender BMI and activity level before the 
knee complaints.    
 
In Chapter 5 the effect of surgical intervention on OA development shown on radiographs and 
MR imaging is reported in Chapter 2. Additionally, we investigated the short-term and long-term 
clinical effects of surgical management of the knee complaints in knee patients with traumatic 
knee complaints but without knee locking. Meniscetomy is commonly performed in patients with 
knee complaints and meniscal tears (32). Recent publications showed no benefits of 
meniscectomy compared to conservative therapy in patients with degenerative meniscal tears (33-
35). It is suggested that knee locking in patients with meniscal tears could be considered an 
indication for surgical treatment but there remains controversy on the surgical management of 
traumatic meniscal lesions, especially in those patients without locking symptoms (36). We 
evaluated the long term clinical effect of meniscectomy in patients with knee complaints without 
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ACL lesions and with at least one traumatic tear but without symptoms of knee locking. 
Differences in knee function and symptoms scores at ten year follow-up were compared between 
surgically and non-surgically treated patients. 
 
The purpose of this study described in  Chapter 6 was to examine the contribution of the OA 
susceptibility genes ASPN,  GDF5, DIO2 and the 7q22 region to radiographic development of 
knee osteoarthritis (OA) in patients with a mean age of  40.6 years ± 7.9 (SD) who suffered from 
non-acute knee complaints a decade earlier. A dose response association of  4 SNP’s on the 
susceptibility genes ASPN,  GDF5, DIO2 and the 7q22 locus were determined by comparing 36  
patients who showed development of OA on radiographs with 88 patients who had no 
development of OA on radiographs and normal cartilage on MRI. OA development was defined 
as a Kellgren and Lawrence (K&L) score >1. Multivariate logistic regression analysis including the 
variables age, gender, body mass index (BMI) and reported knee trauma was performed to 
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Abstract 
Purpose 
To define localized development of knee osteoarthritis (OA) that arises from anterior cruciate 
ligament (ACL) and meniscal injuries identified at magnetic resonance (MR) imaging performed 
a decade ago and the subsequent management of those findings in patients with subacute knee 
symptoms. 
Materials and Methods 
The present study was approved by local medical ethics review boards, and written informed 
consent was obtained. Three hundred twenty-six patients (mean age, 42 years; 108 female) from a 
previously reported series of 855 patients were followed up with regard to the effect of MR 
imaging–guided treatment for subacute knee problems. The mean follow-up period was 10 years. 
Initial findings and treatment were compared with the follow-up radiograph and 3.0-T MR image 
findings. Odds ratios (ORs), with corresponding 95% confidence intervals, were used to identify 
the effects between variables. 
Results 
Patients with ACL ruptures had an increased risk of developing joint space narrowing (JSN), 
cartilaginous defects, osteophytes, bone marrow lesions, and subchondral cysts medially or 
laterally (OR, 2.4–9.8). Patients with medial meniscal tears had an increased risk of developing 
JSN, cartilaginous defects, osteophytes, and bone marrow lesions medially (OR, 2.0–15.3). 
Patients with lateral meniscal tears had an increased risk of developing JSN, cartilaginous defects, 
osteophytes, bone marrow lesions, and subchondral cysts laterally (OR, 2.1–10.5). Meniscectomy 
had no effect on the risk of developing OA. 
Conclusion 
Localized knee OA developed from risk factors identified from the findings of MR imaging 
performed a decade ago in patients with subacute knee symptoms and did not depend on 
the surgical treatment of those findings. 
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Introduction 
Osteoarthritis (OA) of the knee is a common public health problem. More than 30% of the 
population that is aged 60 years or older has radiographically detectable knee OA (1). Knee OA 
has been primarily visualized and assessed on radiographs by using the Kellgren and Lawrence 
(KL) scoring system (2). Investigators in large prospective studies have used radiographs with 
follow-up times of 10–22 years to assess the effect of meniscal and anterior cruciate ligament 
(ACL) lesions on the development and progression of knee OA (3–10).  
Magnetic resonance (MR) imaging, owing to its ability to depict cartilage damage, subchondral 
bone, and bone marrow lesions, has potential advantages in assessing the development of OA 
(11,12). Recently published MR imaging studies, however, have been cross-sectional or have 
involved a maximal follow-up time of only 3 years (13–16). 
Ten years ago, the effect of MR imaging–guided treatment on the outcomes of 855 patients with 
subacute knee problems was studied (17). The aim of the present study was to define localized 
knee OA detected at radiography and 3.0-T MR imaging that developed from risk factors 
identified on MR images obtained a decade ago and the subsequent management of those 
findings in patients with subacute knee symptoms 10 years ago. 
 
Material and Methods 
Study population 
The current study was approved by the medical ethics review boards of the three participating 
hospitals, and written informed consent was obtained from each participant. Patient records were 
retrieved from the database of a previous prospective study, which was performed in 1996 and 
1997 in three different hospitals. The study sponsor (Dutch Arthritis Association) had no 
involvement in the study design, data collection, data analysis, or results interpretation. 
The objective of the previous study was to evaluate the diagnostic value of knee MR imaging 
relative to arthroscopy in patients with subacute knee problems (17). Subacute knee problems 
were defined as persistent knee problems lasting for more than 4 weeks. Only patients with 
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persistent knee problems lasting for more than 4 weeks who sought physician attention were 
included. A total of 855 patients between the ages of 16 and 45 years (mean age, 31 years ± 8.0 
[standard deviation]) participated. Exclusion criteria were knee problems lasting less than 4 
weeks, clinical symptoms of a locked knee, known inflammatory diseases such as rheumatoid 
arthritis, known OA (KL score 4), or history of knee surgery. All participants underwent physical 
knee examination, MR imaging, and radiography of the knee. Knee arthroscopy was performed 
randomly in 161 (50%) of 321 patients with abnormal clinical examination results and normal 
MR findings. 
The current study is a follow-up of the above described study population (mean follow-up, 10 
years ± 0.90). All 855 patients from the original cohort were invited by mail for follow-up. A total 
of 326 patients (38%) were included. Of the 529 excluded subjects, five patients had died, 21 
patients were excluded because of MR imaging or radiographic contraindications, 87 patients 
refused participation, and 416 patients did not respond to the contact letter sent by mail, a second 
letter sent after 2 months, or the three contact attempts by telephone. To assess for selection bias 
in the follow-up study, the patient characteristics of the follow-up study population were 
compared with those of the initial study (Table 1).  
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Table 1 
Differences in Patient Characteristics between Original and Current Study 
 
Patients not included  
in the current study 
population 
( n = 529) 
Current populati-
on 
( n = 326) 
P-Value 
 
Age distribution 30 (median age) 32 (median age) 0.006* (Mann-Whitney) 
Number of women 173 (33%) 108 (33%) 1.000  (Chi-square test) 
ACL ruptures 50 (10%) 48 (15%) 0.021* (Chi-square test) 
MM tears 162 (31%) 119 (37%) 0.072  (Chi-square test) 
LM tears 104 (20%) 68 (21%) 0.725  (Chi-square test) 
No meniscus tears or 
ACL rupture 
283 (54%) 151 (47%) 0.048* (Chi-square test) 
LM = lateral meniscus, MM = medial meniscus. *Significant difference. 
 
Clinical data regarding the length and severity of symptoms were measured by using the Noyes 
knee scoring system for function and symptoms (18,19). Noyes scores were determined at the 
time of inclusion, after 3 and 6 months, and after 10 years. 
Radiographs and MR images of the knee that was symptomatic 10 years ago were acquired. The 
time interval between these follow-up examinations was less than 2 weeks. ACL and meniscal 
injuries detected on the initial 0.5-T MR and/or arthroscopic images were compared with findings 
on the follow-up radiographs and 3.0-T MR images. 
 
Radiographic knee examination and assessment 
Standardized weight-bearing posterior-anterior knee radiographs were obtained with the knee in 
a semi-flexed position (20). Supine lateral radiographs of the knee were also obtained. An 
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experienced musculoskeletal radiologist (I.W., 30 years of musculoskeletal radiology experience) 
and a research fellow (K.H.) scored the radiographs for features of OA. Overall severity was 
scored by using the KL system (2). Radiographs were also scored on a scale of 0–3 for joint space 
narrowing (JSN) assigned to three regions: the medial tibiofemoral compartment, the lateral 
tibiofemoral compartment, and the patellofemoral compartment. Osteophytes were assigned to 
five regions: the medial femoral compartment, the medial tibiofemoral compartment, the lateral 
femoral compartment, the lateral tibiofemoral compartment, and the patellofemoral 
compartment. JSN and osteophytes were scored by using the Osteoarthritis Research Society 
International atlas (21). A lesion was considered to be present when a score of 1–3 was given. 
 
MRI knee examination and assessment 
For the first MR study, a 0.5-T system (Gyroscan T5; Philips Medical Systems, Best, The 
Netherlands) was used. The MR imaging protocol consisted of three sequences: sagittal and 
coronal dual spin-echo sequences and a sagittal T1-weighted three-dimensional gradient-echo 
sequence with frequency-selective fat suppression. Ten years ago, one of six radiologists 
(including J.L.B.) with at least 4 years of experience with musculoskeletal MR imaging evaluated 
the initial 0.5-T MR images in each patient. The locations and types of meniscal tears and ACL 
ruptures were scored. For the follow-up study, the initial 0.5-T MR images were compared with 
the follow-up 3.0-T MR images and were reinterpreted in consensus by an experienced 
musculoskeletal radiologist (I.W.) with more than 20 years of MR imaging experience and a 
research fellow (K.H.). In 51 subjects who received a diagnosis of meniscal degeneration 10 years 
ago and in three subjects who initially received a diagnosis of meniscal tear, the 0.5-T MR images 
were considered to be normal in the current consensus reading. The corrected interpretations for 
these 54 patients were used for analysis in the current follow-up study. 
The follow-up MR imaging examinations were performed by using a 3.0-T system (Achieva 3T; 
Philips Medical Systems). The MR imaging protocol comprised six sequences: coronal and 
transverse fast spin echo with fat suppression, coronal and sagittal fast spin echo with driven 
equilibrium, and transverse and sagittal gradient echo with water excitation. 
 25  
The parameters for coronal and transverse fat-suppressed fast spin-echo MR imaging were 
repetition times of 2625 and 1247 msec for the coronal and transverse planes, respectively. For 
both planes, the echo time was 34 msec, the field of view was 150 mm, and the matrix was 304 × 
238. A 3-mm section thickness with a 0.60-mm intersection gap for coronal imaging and a 4-mm 
section thickness with a 0.80-mm intersection gap for transverse imaging were used. The 
parameters for sagittal and coronal fast spin-echo imaging with driven equilibrium were 3000/34 
(repetition time msec/echo time msec) and a field of view of 150 mm. In the sagittal plane, a 
matrix of 304 × 238 and a 3.5-mm section thickness with a 0.70-mm intersection gap were used, 
and in the coronal plane, a matrix of 304 × 242 and a 3-mm section thickness with a 0.60-mm 
intersection gap were used. The parameters for sagittal and transverse three-dimensional 
gradient-echo imaging with water excitation were a 35° flip angle, 16/9.21, a 150-mm field of 
view, a matrix of 304 × 512, and 0.75-mm section thickness. The imaging time for the entire MR 
imaging protocol was 28 minutes 22 seconds. 
Two experienced musculoskeletal radiologists (J.L.B., I.W., more than 20 years of MR experience) 
and a research fellow (K.H.), who were blinded to the patient characteristics, scored all of the 
acquired data in consensus by using the validated knee osteoarthritis scoring system (22). Lesions 
were localized to any of five regions: medial femoral compartment, medial tibiofemoral 
compartment, lateral femoral compartment, lateral tibiofemoral compartment, and 
patellofemoral compartment. 
The scored parameters were focal and diffuse cartilaginous defects. A focal cartilaginous defect 
was defined as an abrupt transition (acute angle) between the cartilage defect and the surrounding 
cartilage. A diffuse cartilaginous defect was defined as a smooth and gradual transition between 
normal and thinned cartilage. When a focal chondral defect was superimposed on diffuse 
cartilage loss, both defects were scored. Other scored parameters were meniscal tears (Fig 1) and 
subluxations, osteophyte formation, bone marrow lesions, and subchondral cysts (Figs 2 and 3). 
With the knee osteoarthritis scoring system, values of 0 (absent) to 3 (severe) are assigned to the 
MR imaging–depicted features (22). A lesion was considered to be present when a score in the 
range of 1–3 was given. 
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Figure 1: 
Sagittal 0.5-T intermediate-weighted spin-echo MR image (2250/20) shows MM tear in 29-year-old 




Figure 2:  
Sagittal three-dimensional gradient-echo MR image shows cartilaginous defect (arrow) and bone 
marrow lesion in lateral femoral condyle in 54-year-old woman with ACL rupture and meniscal tears 
10 years ago. This sequence was used to score the cartilage lesions. Fat-suppressed fast spin-echo 
sequence was used to score the bone marrow lesion. The ACL rupture was not reconstructed, and the 
MM tear was treated with partial meniscectomy. 
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Figure 3:  
Coronal fat-suppressed fast spin-echo MR image in 46-year-old man shows ill-defined bone marrow 
edema–like pattern in lateral tibial condyle (arrow) and cartilage loss in lateral tibia. Patient had torn 




To determine the prevalence of structural abnormalities, the arthroscopic and MR imaging 
findings from the initial study were used; in the patients who did not undergo arthroscopy, the 
MR findings were used. The follow-up radiographic and MR results were categorized in a binary 
fashion as normal or abnormal. 
The Mann-Whitney test was used to compare differences in age distribution, and the 2 test was 
used to compare differences in sex and structural abnormalities between the current study 
population and the patients who participated in the initial study but were not included in the 
current study population. The 2 test was used to determine if there were differences in OA 
development among the knees with different structural abnormalities detected with MR imaging 
or arthroscopy. One-way analysis of variance was used to compare the Noyes knee function and 
symptom scores among five groups: patients with ACL ruptures, patients with medial meniscal 
tears, patients with lateral meniscal tears, patients with combined ACL ruptures and/or meniscal 
tears, and patients without ACL ruptures or meniscal tears. 
Odds ratios (ORs), with 95% confidence intervals (CIs), were used to show the association 
between different risk factors and presence of OA features 10 years after subacute knee problems. 
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Multivariate logistic regression models were used to assess the association between MR imaging 
findings 10 years earlier and subsets of knee OA based on current MR imaging results while 
adjusting for age, sex, and body mass index. Age and body mass index were analyzed as 
continuous variables. When the odds ratio estimates were zero, exact logistic regression was used 
to obtain upper 95% CI limits. 
 
All tests were two tailed, and P < .05 was considered to indicate statistical significance. All 
statistical analyses were performed by using SPSS, version 16.0.2, for Windows (SPSS, Chicago, 




The median age of the 326 patients whose data were included in the follow-up study was 42 years 
(mean age, 42 years ± 7.6 [standard deviation]). At the time of their inclusion in the initial study 
10 years ago, their median age was 32 years (mean age, 32 years ± 7.7), which differed from the 
median age of the 529 patients not included in the current study population (30 years; mean age, 
30 years ± 8.1, P = .006) (Table 1). At the current follow-up, 108 (33%) patients were female; this 
was the same percentage of female patients as that in the original study (n = 281[33%]) and in the 
cohort of patients not included in the current study (n = 173 [33%]) (Table 1). More ACL 
ruptures were found in the current study population (48 [15%]) than in the group of patients not 
included (50 [9%]) (P = .021) (Table 1). Furthermore, the frequency distribution of meniscal 
lesions found 10 years ago among the patients not included in the current study was similar to 
that in the current study population (Table 1). 
The follow-up population can also be considered representative of the initial study population in 
terms of surgical history. The partial meniscectomies performed in 263 (31%) patients in the 
original study population within 6 months after inclusion 10 years ago were not significantly 
different from the 115 (35%) meniscectomies performed 10 years ago in the follow-up population 
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within 6 months after inclusion. An additional 14 (4%) patients in the follow-up population 
underwent a partial meniscectomy after 6 months but within 10 years of follow-up. Because of the 
nonresponders, the number of partial meniscectomies performed after 6 months in the complete 
initial population is not available. 
The Noyes knee function and symptom scores (18,19) at the time of inclusion, after 3 and 6 
months, and after 10 years were not significantly different between patients with an ACL rupture, 
patients with a medial meniscal tear, patients with a lateral meniscal tear, patients with combined 
ACL ruptures and/or meniscal tears, and patients without ACL ruptures or meniscal tears (P .05 
for all comparisons). No major trauma was reported by any patient during the 10-year interval; 
no information about minor injuries was available. 
Ten years ago, most meniscal tears—110 (94%) of 117 MM tears and 48 (73%) of 66 LM tears—
were found in the posterior horn and body. Of the 117 MM tears, two (2%) were smaller than 0.5 
cm, 90 (77%) were larger than 0.5 cm, and 25 (21%) were bucket-handle tears. Of the 66 LM tears, 




In the knees with ACL rupture, 16 ACLs (33%) were reconstructed. The majority of these 
reconstructions (13 [81%]) were performed within 2 years after inclusion in the initial study. 
Partial meniscectomy was performed in 129 (71%) (86 MM, 43 LM) of the 183 knees with 
meniscal tears. The other 54 (29%) (31 MM, 23 LM) tears were treated conservatively. The 
majority (115 [89%])of the meniscectomies were performed within 6 months after inclusion in 
the initial study. Meniscectomy was performed in 25% of the 16 meniscal tears smaller than 0.5 
cm (0 MM, four LM), in 71% of the 137 meniscal tears larger than 0.5 cm (62 MM, 35 LM), and in 
93% of the 30 bucket-handle tears (24 MM, four LM). 
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Radiographic sequelae  
ACL lesions.—In patients with ACL ruptures, an increased risk of advancing more than one point 
in the KL score over 10 years was found (OR, 2.8). There was an increased risk of developing JSN 
in the medial tibiofemoral compartment (OR, 5.5) and an increased risk of developing 
osteophytes in the medial femoral (OR, 7.0) and medial tibiofemoral (OR, 2.0) compartments 
(Table 2) (Fig 4a). 
 
MM lesions.—In the knees with torn MMs, there was an increased risk of advancing more than 
one point in the KL score (OR, 2.0). There was an increased risk of developing JSN (OR, 15.3) and 
of developing osteophytes (OR, 3.9) in the medial tibiofemoral compartment (Table 2) (Fig 5a). 
Differences in the size and location of the MM tears had no significant effect on the risk of 
developing these radiographic features. 
 
LM lesions.—Patients with LM tears had an increased risk of advancing more than one point in 
the KL score over 10 years (OR, 2.3). There was an increased risk of developing JSN in the lateral 
medial tibiofemoral compartment (OR, 10.7) and an increased risk of developing osteophytes in 
the lateral tibiofemoral (OR, 4.8) and patellofemoral (OR, 2.1) compartments (Table 2) (Fig 6a). 
Differences in the size and location of the LM tears had no significant effect on the risk of 
developing these radiographic features. 
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Table 2 Radiographic Sequelae in Relation to Old Meniscal Tears and ACL Ruptures 
 
 ACL rupture  n = 48  MM tear    n = 117  LM tear  n = 66 
 OR 95% CI P value  OR 95% CI P value  OR 95% CI P value 
K&L Diffe-
rence >1 
2.8 1.2-6.4 0.013*  2.0 1.0-4.1 0.047*  2.3 1.1-4.8 0.023* 
JSN Medial 
TFC 
5.5 1.6-18.6 0.006*  15.3 3.3-71.8 0.001*  0.8 0.2-2.6 0.673 
JSN Lateral 
TFC 
1.4 0.5-4.4 0.516  0.5 0.2-1.4 0.158  10.7 3.8-29.8 <0.001* 
JSN PFC 0.5 0.0-3.7 0.569  0.3 0.0-2.5 0.286  2.9 0.4-21.6 0.287 
Osteophytes 
MFC 
7.0 1.5-33.6 0.015*  3.9 0.7-21.2 0.111  1.4 0.3-7.0 0.659 
Osteophytes 
MTC 
2.0 1.1-5.7 0.032*  4.2 2.1-8.7 <0.001*  1.1 0.5-2.5 0.742 
Osteophytes 
LFC 
0.4 0.0-2.5 0.365  2.0 0.4-11.0 0.445  3.2 0.6-16.1 0.166 
Osteophytes 
LTC 
1.7 0.7-4.4 0.282  1.0 0.5-2.3 0.967  4.8 2.2-10.6 <0.001* 
Osteophytes 
PFC 
0.9 0.4-2.0 0.720  1.0 0.5-1.9 0.964  2.1 1.1-4.1 0.034* 
LFC = lateral femoral compartment, LTC = lateral tibial compartment, MFC = medial femoral 
compartment, MTC = medial tibial compartment, PFC = patellofemoral compartment. *Significant 
difference. 
 
MR Imaging sequelae 
ACL lesions.—Patients with an ACL tear 10 years ago had an increased risk of developing diffuse 
cartilaginous lesions in the medial tibiofemoral compartment (OR, 4.1) and/or focal cartilaginous 
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lesions in the lateral femoral (OR, 3.0) and/or lateral tibiofemoral (OR, 3.1) compartment. They 
also had an increased risk of developing a subluxation of the MM (OR, 6.7) and of developing 
osteophytes in the medial femoral (OR, 3.8), medial tibiofemoral (OR, 3.0), and/or lateral 
tibiofemoral (OR, 2.7) compartment. Patients with ACL ruptures had an increased risk of 
developing bone marrow lesions (OR, 5.5) and subchondral cysts (OR, 9.8) in the lateral femoral 
compartment (Tables 3–7, Fig 4b). 
 
MM lesions.—Patients with MM tears had an increased risk of developing MR imaging–
detectable diffuse cartilaginous defects in the medial femoral (OR, 2.8) and/or medial tibiofemoral 
(OR, 3.6) compartment. There was an increased risk of developing MM subluxations (OR, 2.9) 
and a reduced risk of developing LM subluxation (OR, 0.2). There was an increased risk of 
developing osteophytes (OR, 2.8) and bone marrow lesions (OR, 4.1) in the medial tibiofemoral 
compartment. Patients with MM tears did not have an increased risk of developing subchondral 
cysts in any compartment (Tables 3–7) (Fig 5b). Differences in the size and location of the MM 
tears had no significant effect on the risk of developing these MR features. 
 
LM lesions.—Patients with LM tears had an increased risk of developing focal cartilaginous 
lesions in the lateral tibiofemoral (OR, 2.9) and/or lateral femoral (OR, 3.3) compartment. There 
was an increased risk of developing a subluxation of the LM (OR, 10.5) and osteophytes in the 
lateral femoral compartment (OR, 2.5). Patients with LM tears had an increased risk of 
developing bone marrow lesions in the lateral tibiofemoral compartment (OR, 4.4) and a 
decreased risk of developing bone marrow lesions in the patellofemoral compartment (OR, 0.2). 
There was an increased risk of developing subchondral cysts in the lateral tibiofemoral 
compartment (OR, 4.1) (Tables 3–7) (Fig 6b). Two patients with LM bucket-handle tears 
developed bone marrow lesions in the lateral femoral compartment. None of the patients with 
smaller LM tears developed bone marrow lesions in the lateral femoral compartment, and the 
difference between these two groups was significant (P = .008). No other differences related to the 
size or location of the LM lesions were observed. 
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Figure 4:(a) Drawing shows characteristic abnormalities, as seen on radiographs, that have increased 
risk of developing after rupture of ACL: JSN and osteophytes medially. (b) Drawing shows 
characteristic abnormalities, as seen on MR images, that have increased risk of developing after 
rupture of ACL: diffuse cartilaginous defects and osteophytes medially, and focal cartilaginous defects, 




Figure 5:(a) Drawing shows characteristic abnormalities, as seen on radiographs, that have 
increased risk of developing after MM tear: JSN and osteophytes medially. (b) Drawing shows 
characteristic abnormalities, as seen on MR images, that have increased risk of developing after MM 
rupture: diffuse cartilage defects, osteophytes, and bone marrow lesions medially. 
 a b 
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Figure 6a:(a) Drawing shows characteristic abnormalities, as seen on radiographs, that have 
increased risk of developing after LM tear: JSN and osteophytes laterally. (b) Drawing shows 
characteristic abnormalities, as seen on MR images, that have increased risk of developing after LM 
rupture: focal cartilaginous defects, osteophytes, bone marrow lesions, and subchondral cysts laterally. 
a b 
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Table 3 Focal and Diffuse Cartilage Defects in Relation to Old Meniscal Tears and ACL Ruptures 
 
  ACL rupture  n = 48 MM tear    n = 117 LM tear  n = 66 
Compartment Cartilage Defects OR 95% CI P value OR 95% CI P value OR 95% CI P value 
MFC Focal 1.2 0.7-2.1 0.242 0.9 0.5-1.6 0.755 0.7 0.3-1.4 0.284 
 Diffuse 1.7 0.7-4.2 0.274 2.8 1.4-5.8 0.006* 0.8 0.3-1.8 0.537 
MTC Focal 1.3 0.3-4.9 0.725 0.5 0.2-1.5 0.216 1.0 0.3-3.3 0.999 
 Diffuse 4.1 1.5-11.2 0.006* 3.6 1.4-8.9 0.006* 0.5 0.2-1.5 0.218 
LFC Focal 3.0 1.4-6.4 0.004* 0.7 0.4-1.5 0.393 2.9 1.5-5.7 0.002* 
 Diffuse 1.4 0.6-3.6 0.453 0.7 0.3-1.6 0.440 0.5 0.2-1.5 0.218 
LTC Focal 3.1 1.3-7.3 0.009* 0.2 0.1-0.6 0.004* 3.3 1.5-7.3 0.002* 
 Diffuse 0.8 0.1-4.0 0.738 2.0 0.7-5.9 0.231 1.6 0.5-5.1 0.397 
PFC Focal 0.8 0.4-1.6 0.574 1.2 0.7-2.1 0.406 0.7 0.4-1.2 0.213 
 Diffuse 1.0 0.4-2.5 0.921 1.1 0.6-2.2 0.783 0.7 0.4-2.5 0.921 
*Significant difference. LFC = lateral femoral compartment, LTC = lateral tibial compartment, MFC = medial femoral compartment, MTC = medial 
tibial compartment, PFC = patellofemoral compartment.  
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Table 4 Meniscal Subluxation and Newly Developed Meniscal Tears in Relation to Old Meniscal Tears and ACL Ruptures 
Meniscal findings ACL rupture  n = 48  MM tear    n = 117  LM tear  n = 66 
 OR 95% CI P value  OR 95% CI P value  OR 95% CI P value 
MM subluxation 6.7 2.1-21.0 <0.001*  2.9 1.0-8.3 0.049*  1.1 0.4- 3.4 0.886 
LM subluxation 0.5 0.1-2.0 0.312  0.2 0.06-0.7 0.009*  10.5 3.8-28.7 <0.001* 
New MM tear 2.9 1,0-9.3 0.069  0.1 0.0-2.7 <0.001*  0.3 0.1-1.4 0.114 
New LM tear 2.1 0.5-9.1 0.303  0.1 0.02-1.0 0.052  0.2 0.0-1.1 0.066 
*Significant difference. MM=medial meniscus, LM=lateral meniscus 
Table 5 MR Imaging–depicted Osteophytes in Relation to Old Meniscal Tears and ACL Ruptures 
Osteophytes ACL rupture  n = 48  MM tear    n = 117  LM tear  n = 66 
Compartment OR 95% CI P value  OR 95% CI P value  OR 95% CI P value 
MFC 3.8 1.8-8.1 <0.001*  1.9 1.0-3.6 0.065  1.5 0.7-3.0 0.305 
MTC 3.0 1.2-7.2 0.014*  2.8 1.3-6.1 0.007*  1.4 0.6-3.2 0.408 
LFC 1.1 0.4-3.4 0.819  1.0 0.4-2.5 0.980  2.5 1.0-6.2 0.040* 
LTC 2.7 1.1-6.4 0.024*  0.5 0.2-1.2 0.106  2.1 0.9-4.7 0.073 
PFC 1.5 0.7-2.9 0.276  1.1 0.6-1.9 0.775  1.0 0.6-1.9 0.928 
*Significant difference. LFC = lateral femoral compartment, LTC = lateral tibial compartment, MFC = medial femoral compartment, MTC = medial 
tibial compartment, PFC = patellofemoral compartment.  
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Surgical treatment and differences in Radiographic and MRI sequelae 
The ORs for all structural abnormalities in the patients treated with ACL reconstruction or partial 
meniscectomy were not significantly different from those for the patients who were not treated. 
(All 95% CIs for ORs included an OR equal to 1.) In terms of the manifestation of all OA features 
in all compartments after 10 years, it made no difference if the initial ACL, MM, or LM lesion was 
detected at MR imaging or arthroscopy (P .05 for all comparisons). 
Meniscal tears were also present in 31 (65%) knees with ACL ruptures. Logistic regression 
analysis revealed that the increased risk of developing OA was not dependent on meniscal lesions, 
but rather it could be attributed to ACL rupture only. None of the structural abnormalities 
evaluated 10 years ago indicated an increased risk of developing meniscal tears. (All 95% CIs for 
ORs included an OR equal to 1 [Table 4].) 
 
Discussion 
Localized knee OA developed, irrespective of treatment, from ACL and meniscal injuries 
identified at MR imaging performed a decade ago in patients with subacute knee symptoms. 
Patients who have had an ACL rupture and/or a meniscal tear have a significantly increased risk 
of developing JSN, cartilage lesions, osteophytes, and/or bone marrow lesions. 
Treatment, partial meniscectomy and ACL reconstruction in particular, did not decrease the risk 
of developing the features of OA demonstrated on radiographs or MR images. This is in contrast 
to results reported previously (4). Englund et al (4) examined 155 patients with isolated meniscal 
tears who were treated with meniscectomy. Their results showed that, 16 years later there was an 
increased risk of developing radiographically detectable knee OA in patients whose meniscal tears 
were treated with meniscectomy as compared with this risk in a control group. The results of our 
study, however, show that, after 10 years, patients with meniscal tears have an increased risk of 
developing radiographic OA, but partial meniscectomy has no significant effect (positive or 
negative) on the development of radiographically detectable OA. Because Englund et al (4) 
examined patients who had undergone meniscectomy only, it is not clear to what extent the 
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development of OA in that study population could be attributed to the meniscal tear and to what 
extent it could be attributed to meniscectomy. 
More abnormalities were found on the MR images than on the radiographs, in accordance with 
previously reported observations that MR imaging enables a more detailed and comprehensive 
display of OA-related changes than does radiography (11,12). 
With rupture of the ACL, increased internal tibial rotation and anterior tibial translation occur 
(23–28). This leads to a higher point rotation pressure in the medial knee compartment and 
higher shearing forces in the medial and lateral compartments. Shearing forces are important in 
developing cartilaginous defects, because cartilage is known not to withstand shear stress as well 
as compressive forces (29–31). As a consequence, 10 years after ACL rupture, MR images depict 
diffuse cartilaginous lesions in the medial tibiofemoral compartment (OR, 4.1) and focal 
cartilaginous lesions in the lateral femoral (OR, 3.0) and lateral tibiofemoral (OR, 3.1) 
compartments. Our result of an increased risk of OA development in the patients with isolated 
ACL ruptures differed from the findings of Neuman et al (9). They found that 15 years after ACL 
rupture, only those patients who were also treated with meniscectomy developed radiographically 
detectable OA. However, as stated by Neuman et al, because of the low incidence of knee OA and 
the small sample size, multivariate modeling of multiple risk factors was not performed in their 
statistical analysis. In our study, multivariate modeling was used to compare the risks of 
developing OA after ACL and meniscal lesions. The effect of surgical treatment on the 
development of OA in these groups was analyzed separately. This makes it difficult to compare 
the outcomes of both studies. 
Menisci are important load transmitters (32). The results of our study show that there is an 
increased risk of developing cartilaginous lesions after meniscal tears. This is in concordance with 
the results of other MR imaging studies (4,13,14,16). Our results show that there is an increased 
risk of developing diffuse cartilaginous defects medially in patients who have had MM tears and 
an increased risk of developing focal cartilaginous defects laterally after LM tears. A possible 
explanation for these findings is that with normal knee movements, rotation occurs mainly 
around a medially positioned axis, resulting in shear stress at the lateral articular surface and 
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point rotation pressure at the medial surface (33,34). Because cartilage is less tolerant to shearing 
forces, the impaired load transmission of torn menisci has a greater effect on the lateral 
compartment, increasing the risk of developing focal cartilaginous defects. The increased point 
rotation pressure in combination with the increased joint load medially during walking (35) 
might cause the anatomically vulnerable MM (32) to tear and increase the risk of developing 
diffuse cartilaginous defects medially. 
Radiographically depicted JSN is reportedly influenced by meniscal position, meniscal 
degeneration, and cartilaginous defects (36). The results of our study show that after ACL 
rupture, there is an increased risk of developing medial JSN, which can contribute to the 
increased risk of developing cartilage lesions in the medial tibiofemoral compartment (OR, 4.1) 
and/or MM subluxations (OR, 6.7). The increased risk of developing JSN meniscal tears in the 
ipsilateral tibiofemoral compartment can be explained by the increased risk of developing 
cartilaginous lesions (OR range, 2.8–3.6 [Table 3]), the increased risk of developing meniscal 
subluxations (OR: 2.9 for MM, 10.5 for LM), and/or the meniscal tear itself. Although osteophytes 
can develop without explicit cartilage damage (37), the increased risk of developing 
radiographically and MR imaging–detectable osteophytes seems to be related to the presence of 
cartilaginous defects. In three of four radiographically determined locations and four of five MR 
imaging–determined locations with an increased risk of developing osteophytes, there was also an 
increased risk of developing cartilaginous lesions. 
The development of MR imaging–detectable patellofemoral OA features was not related to ACL 
or MM lesions, but the risk of developing radiographically detectable osteophytes in the 
patellofemoral joint after LM tearing was increased (OR, 2.1). These results are in accordance 
with previous study findings that indicated that other risk factors may be involved in 
patellofemoral OA as opposed to tibiofemoral OA (38–41). The increased risk of radiographically 
detectable patellofemoral osteophytes and the decreased risk of bone marrow lesions in knees 
with LM tears might be explained by varus malalignment and erratic rotational movements at the 
femorotibial articulation with subsequent abnormal patellofemoral stresses (42). 
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The main limitation of the present study was the large number of patients lost to follow-up (529 
[62%] of 855 patients). There are some possible reasons for this limited response rate. The study 
originally was not designed to be a follow-up investigation, and all patients had to be traced and 
asked to participate. Because the study population was relatively young, it was difficult to trace all 
patients: Often, their addresses and phone numbers had changed during the 10 years. Another 
limitation of the study was that only those patients with persistent knee problems might have 
been interested in participating in the follow-up study, possibly biasing the results. To investigate 
this, all 87 subjects who refused participation were asked if they still had knee problems. The 
majority of these subjects, 49 (56%) patients, had knee problems, but they also had other reasons 
for not participating in the study. Furthermore, no significant differences in population 
characteristics between the complete initial (n = 855) and current study (n = 326) populations 
were found (P .05 for all comparisons). However, when the current study population was 
compared with the 529 patients who participated in the initial study but were not included in the 
current study population, there were some significant differences. The current population was 
slightly older at the time of inclusion 10 years ago (mean age, 32 years ± 7.7) compared with the 
initial study subgroup (mean age, 30 years ± 8.1) (P = .006) and had more ACL lesions (48 [15%] 
compared with 50 [9%] in the initial study subgroup [P = .021]) (Table 1). There were no 
significant differences in meniscal tears (P .005). These results suggest that the current 
population could be considered representative of the initial study group; only the age and 
frequency of the ACL ruptures were different; therefore, selection bias for these two items cannot 
be excluded. 
In summary, irrespective of treatment, the risk factors seen on knee MR images resulted in 
localized development of OA 10 years later. The different patterns of developing OA are 
determined according to the initial ACL and meniscal injuries and can be explained by ensuing 
changes in biomechanical loading. The hallmark finding of OA development after MM tears is 
diffuse medial cartilage loss, and after LM tears, it is focal lateral cartilage loss. After ACL rupture, 
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Objective. To validate a newly developed quantification method that automatically detects and 
quantifies the joint space width (JSW) in hand radiographs. Repeatability, accuracy and sensitivity 
to changes in JSW were determined. The influence of joint location and joint shape on the 
measurements was tested.  
 
Methods. A mechanical micrometer set-up was developed to define and adjust the true JSW in an 
acrylic phantom joint and in human cadaver-derived phalangeal joints. Radiographic 
measurements of the JSW were compared to the true JSW. Repeatability, systematic error 
(accuracy) and sensitivity (defined as the smallest detectable difference (SDD)) were determined. 
The influence of joint position on the JSW measurement was assessed by varying the location of 
the acrylic phantom on the X-ray detector with respect to the X-ray beam and the influence of 
joint shape was determined by using morphologically different human cadaver joints. 
 
Results. The mean systematic error was 0.052 mm in the phantom joint and 0.210 mm in the 
cadaver experiment. In the phantom experiments, the repeatability was high (SDD = 0.028 mm), 
but differed slightly between joint locations (p = 0.046), and a change in JSW of 0.037 mm could 
be detected. Dependent of the joint shape in the cadaver hand, a change in JSW between 0.018 
and 0.047 mm could be detected. 
 
Conclusion. The automatic quantification method is sensitive to small changes in JSW. 
Considering the published data of JSW decline in the normal and osteoarthritic population, the 




Osteoarthritis (OA) is a common chronic medical condition in older adults, leading to 
progressive structural damage of the joints and subsequent functional disability(1-3). Although 
the hand is frequently involved in OA patients, leading to pain and impaired hand function, 
osteoarthritis research is focused predominantly on the hip and knee(4-7). Besides patient-
reported outcomes (i.e. pain, physical function and patient global assessment), progressive 
decrease of radiographic joint space width (JSW) is an important parameter in clinical trials on 
hand OA(8-10). Hand radiographs are used commonly to diagnose and monitor hand OA 
because of their wide availability and the relatively low costs. Semi-quantitative methods with 
standard atlases are the bench tools used by clinicians to determine changes in JSW(11-13). 
Although radiographic OA features scored by these methods are widely performed(14;15), there 
is a limitation in reproducibility due to the difficulty to standardize the scoring between different 
readers. The use of an ordinal scale is a limitation to measurement accuracy, which could be 
improved by assessment of structural damage on a continuous metric scale(16).  
At the moment, only symptomatic treatment is available(17), and the development of new 
structure modifying trials on hand OA is hampered by limitations in outcome measures(18). 
Since OA is a slowly progressive disease, an accurate and reproducible method is needed to detect 
subtle changes throughout follow-up, especially when evaluating new therapies. 
Currently, radiography is usually digital, facilitating implementation of computerized quantitative 
JSW measurements. Different software tools have been developed to measure JSW in 
radiographs(19-25). These are mainly semi-automatic tools requiring manual detection of articular 
margins or joint space by the user. A newly developed JSW quantification method automatically 
detects the interphalangeal (IP) and metacarpophalangeal (MCP) joints and quantifies the JSW in 
hand radiographs(26). In a recent cross-sectional study good agreement was found between 
measured JSW by this method and the atlas-based ordinal scores according to the OARSI 
system(26). 
Because the decrease in radiographic JSW is an important surrogate marker in clinical trials on 
hand OA, the primary aim was to assess the accuracy and sensitivity to change in JSW by 
comparing the automatically determined JSW to true distance between bony contours of the finger 
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joints. Since JSW cannot be adjusted in human subjects, this gold standard was obtained by varying 
the true JSW in an acrylic phantom and in cadaver finger joints, using an attached mechanical 
micrometer. The second aim of the study was to evaluate the influence of joint location and joint 
shape on the measured JSW. 
 
Materials and methods 
Three experiments were composed to validate the automated quantification method. In all 
experiments a specially developed micrometer device was used to define and adjust the true JSW. 
Plain digital radiographs were acquired by a standard digital X-ray imaging system (Canon Inc., 
Tokyo, Japan) and the resulting images were analyzed by our developed software(26). Subsequently, 
the differences between the measured and true JSW were evaluated. 
In the first experiment, the repeatability of the JSW measurement was tested using an acrylic 
phantom joint, which mimics an MCP joint, attached to the micrometer (Figure 1) with a fixed 
JSW. In the second experiment, the sensitivity to progression was tested by varying the JSW in the 
acrylic phantom and measuring this simulated progression by the automated quantification 
method. In the final experiment, the MCP, the proximal interphalangeal (PIP) and distal 
interphalangeal (DIP) joints of human cadaver bones were attached to the micrometer (Figure 2) in 
order to study the influence of differences in joint shapes on the sensitivity to progression of Joint 
Space Narrowing (JSN). All experiments were repeated for different locations of the joint, 








Fig. 2 The micrometer set-up showing the cadaver metacarpal-phalangeal joint of the 3rd digit. 
Middle and distal phalangeal bones of the 3rd and 5th digit were also used in experiment 3 
  
 
Experiment 1, Repeatability, phantom joint 
In order to test repeatability the acrylic phantom was placed on the hand template at the location 
of the MCP of the 3rd digit (middle finger), to which the X-ray focus was projected, 
perpendicularly to the receptor plate. In order to simulate conditions comparative to (follow-up) 
clinical trials, in which user dependent focus-film distance and (re)positioning differences may 
appear, 10 exposures were made with focus-film distances of 110, 115 and 120 cm (n = 4, 3 and 3, 
respectively), on each occasion repositioning the phantom, table and X-ray focus between 
exposures. The true JSW was set at 1.00mm. The experiment was repeated using the standard 
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anatomical location of the DIP of the 5th digit on the template, which produces the most 
angulated projection. 
Experiment 2, Sensitivity to progression, influence of joint location 
The phantom joint was placed at the positions of the MCP III, PIP III, DIP III, and DIP V on the 
hand template, where the MCP III location is the centre point of the x-ray beam. True JSW was 
varied between 0.20 and 2.40mm. In the intervals (0.20; 0.80) and (1.20; 2.40), this was done with 
an increment of 0.20mm. In the interval (0.90;1.20) a smaller increment of 0.02mm was used, to 
simulate subtle progression rates as probably encountered at the onset of OA (22;23;26). A total of 
88 measurements were performed, 22 for each joint. 
Experiment 3, Sensitivity to progression, influence of joint shape 
In order to study the influence of different joint shapes, we used human cadaver matched 
metacarpal and phalangeal bones of the 3rd and 5th finger, from which all hyaline cartilage and soft 
tissues were dissected. JSW was varied in the same way as described in Experiment 2. The X-ray 
focus was centered at the location of the MCP III, PIP III, DIP III and DIP V joint. A total of 88 
measurements were performed, 22 for each joint. 
  
Image Analysis 
The automatic quantification method first identifies the individual joints in the standard hand 
radiographs(26). Subsequently, the proximal and distal margins and the measurement interval are 
determined in each joint, thereby defining the joint space. Finally the JSW was calculated as the 
average distance between the joint margins enclosed by the measurement interval. In order to 
analyze the radiographs containing the phantom joints, the first step of the program was omitted 
and an observer had to locate the position of the phantom joint manually. 
Statistical analysis  
In the first experiment the standard deviation (SD) of the paired differences between measured 
and true JSW was defined as a measure of repeatability (random error). The smallest detectable 
difference (SDD) or the smallest detectable chance (SDC) is used in OA research as a threshold 
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for detection of JSN, and is defined as 1.96 x SD (27-29). SDs were compared between DIP and 
MCP joints, with the Levene’s test for homogeneity. The mean of the differences gives the 
systematic error. To test the statistical significance of this systematic error in these clustered data, 
we used a Generalized Linear Model (GLM), with the error in JSW as dependent variable, and 
location and exposure number as random factors. Differences in systematic errors between two 
morphologically different joints like the DIP and MCP joint were tested with an unpaired T-test, 
assuming equal variances. Normal distribution of the differences was confirmed with the 
Kolmogorov-Smirnov Test. 
 
In the second and third experiment, a Bland-Altman plot was made to investigate whether the 
systematic error was dependent on the size of the JSW measurement and to calculate the 
repeatability (SD of differences). 
Differences in systematic errors between joint locations (Experiment 2) and between joint shapes 
(Experiment 3) were analyzed with a GLM model, as described above, with location and joint type 
as random factors, respectively, by testing whether the corresponding coefficients were 
significantly different from 0. Differences in random errors between locations and joint types 
were tested with a Levene’s test.  
To test the statistical significance of the systematic error for the entire group, we tested whether 
the intercept in the GLM analysis was significantly different from 0. 
A significance level of 0.05 was used for all statistical tests. 
 
Results 
Experiment 1, Repeatability, phantom joint 
The results (Table 1 and Figure 3) show a systematic error of 0.052 mm (5% over-estimation). 
The systematic error was independent of focus-film distance and not significantly different 
between the DIP V and MCP III location. We found a significant difference in the repeatability 
between the measurement at the DIP V location and the measurement at the MCP III location 
(both P-values 0.046). Highest repeatability was found at the location of the MCP of the 3rd digit. 
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Table 1 Systematic error and repeatability in the phantom joint at different locations. The true JSW 
(micrometer) was set at 1.00 mm 
  Location  
 Entire group (n=20) DIP V (n=10) MCP III (n=10) P-value 
Mean difference [mm] 0.052* 0.047 0.056 0.17 a 
SD of the differences [mm] 0.014 0.016 0.011 0.05 b 
SDD [mm] 0.028 0.032 0.021 0.05 b 
SD: standard deviation, SDD, smallest detectable difference. aStudent T-test; b Levene’s test. 
*Generalized Linear Model: intercept was significantly different from 0, p<<0.01. 
 
 
Fig. 3 Measured JSW by automatic quantification and true JSW for two joint locations 
 
 
Experiment 2, Sensitivity to progression, influence of joint location 
The results (Table 2 and Figure 4) show that the systematic and random errors were 0.054 mm 
and 0.037 mm respectively and both were independent of the size of JSW. These errors were 
slightly higher than in Experiment 1. Again highest repeatability was found at the MCP of the 3rd 
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digit, but no statistically significant differences in random errors were found between the four 
different joint locations (i.e. MCPIII, PIPIII, DIP III and V). Progression of JSN was estimated 
without any systematic error and with a random error of 0.016 mm (Table 3 and Figure 5). 
Therefore progression of 0.032 mm, as defined by the smallest detectable difference, was 
measured in this phantom experiment. 
 
Table 2 Systematic error and SDDs in the phantom joint on different locations 
  Location  
 












Mean difference [mm] 0.054* 0.050 0.056 0.061 0.050 0. 141 
SD of the differences [mm] 0.019 0.020 0.019 0.011 0.022 0.352 
SDD [mm] 0.037 0.038 0.038 0.022 0.043 0.352 
SD: standard deviation, SDD, smallest detectable difference.  1Generalized Linear Model (GLM), 
location contribution; 2 Levene’s test. *GLM: intercept significantly different from 0, p<<0.01. 
 
Table 3 Systematic error and SDDs in the measurement of progression in the phantom joint from a 
true JSW of 1.1 mm at baseline 
  Location 
Progression 










Mean difference [mm] -0.002 -0.002 0.008 -0.009 -0.007 
SD of the differences [mm] 0.016 0.018 0.014 0.012 0.017 
SDD [mm] 0.032 0.035 0.027 0.024 0.033 
SD standard deviation, SDD smallest detectable difference 
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Experiment 3, Sensitivity to progression, influence of joint shape 
The mean systematic error was 0.210 mm (Table 4 and Figure 6) and there was a significant 
difference in the systematic errors between the different joints. The systematic error was smallest 
in DIP V (0.050mm) and highest in PIP III (0.354mm). Progression of JSN in the different joints 
was estimated without any systematic errors (Table 5 and Figure 7). The overall precision in 
detecting progression as defined by the smallest detectable difference was 0.031 mm, being 
smallest in DIP V (0.018mm) and highest in PIP III (0.047mm) (Table 5 and Figure 7).  
 
 
Table 4 Systematic error and SDDs in the cadaver derived joints 
  Joint type  
JSW 











Mean difference [mm] 0.210* 0.268 0.050 0.167 0.354 <<0.01 a 
SD of the diff’s [mm] 0.115 0.011 0.015 0.011 0.024 <0.01 b 
SDD [mm] 0.226 0.022 0.029 0.021 0.047 <<0.01 b 
SD standard deviation, SDD smallest detectable difference aGeneralized linear model (GLM), 
location contribution bLevene’s test *GLM: intercept significantly different from 0, p < <0.01 
 
Table 5 Systematic error and SDDs in the measurement of progression in the cadaver derived joint 
from a true JSW of 1.1 mm at baseline 
Progression 










Mean difference [mm] -0.007 -0.013 -0.005 0.005 -0.017 
SD of the diff’s [mm] 0.016 0.009 0.006 0.008 0.024 
SDD [mm] 0.031 0.018 0.012 0.015 0.047 
SD standard deviation, SDD smallest detectable difference 
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Fig. 6 The difference between true and measured JWS is plotted against the true JSW  
 
Fig. 7 The difference between true and measured progression against the true progression, where a 
true JSW of 1.1 mm was taken as baseline 
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Systematic error in the phantom experiments  
The systematic error of 0.052 mm, found in the phantom studies, did not differ between the 
various focus-film distances. To test if the over-estimation was caused by the software or by the 
phantom design we determined the exact shape and fitting of the phantom joint, by scanning the 
phantom in a micro-CT scanner. This revealed that the distal and proximal surfaces did not fit 
perfectly, leaving a small asymmetric gap (Figure 8). This small additional space was being 





Fig. 8 Sagittal and coronal view of a Micro-CT scan of the acrylic phantom, showing a small 





We validated an automatic method to measure radiographic JSW of the finger joints, for which 
we previously found a good agreement with the atlas-based ordinal score according to the OARSI 
system(26). Results of the current study show that this automatic method has a high accuracy in 
measuring the JSW. We also found a high repeatability (SDD between 0.021 and 0.032), which 
varied slightly between the different hand joint locations. Measured systematic errors were 
between 0.056 mm and 0.047 mm and a progression of JSN between 0.012 and 0.047 mm could be 
detected. Both systematic errors and precision of progression estimation were dependent on the 
joint type, implying that the morphology differences between the MCP, PIP and DIP joints 
influenced the accuracy of JSW measurement. 
 
Repeatability and systematic errors 
The results of Experiment 1 showed that centering the X-ray beam to the location of a particular 
joint improves the repeatability slightly. The differences in repeatability may be explained by x-
ray beam angulation, since the SDD of the measurements on the DIP V location was significantly 
higher than the SDD of the measurements on the MCP III location. The systematic error of 0.052 
mm, found in the phantom studies, was caused by the phantom and not by the measurement 
software.  
A similar phantom experiment was executed by Angwin et al, who studied the sensitivity and 
reliability of mean computerized JSW measurements in standard clinical hand radiographs in 
healthy subjects (19). They used a phantom MCP joint consisting of a gold plated aluminum ball 
and socket mounted on a micrometer to investigate the errors of their measurements method. In 
their phantom experiment an overestimation of JSW of 0.018 mm was found, which is smaller 
than the overestimation in our experiment. It is likely that their overestimation was also caused by 
the phantom model design, leaving a gap between the two components. In the same study, 
Angwin et al. used hand radiographs of healthy subjects to determine the smallest detectable 
difference, where they consequently assumed that repeatability was independent of the size of the 
JSW. In our experiment we could confirm that this is indeed the case. We found however that 
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repeatability is influenced by the shape of the joint and slightly by the joint location, as shown in 
Experiment 2 and 3. 
 
The results of Experiment 3 showed that systematic errors were different between joint types. The 
automatic quantification software calculates a mean JSW depending on the measured area 
between two bony contours, whereas the micrometer device is calibrated on the minimal distance 
between two phalangeal bones. It is likely that the shape of the different joints influences the 
definition of JSW as implemented in the automatic quantification method compared to the 
minimal measured space by the micrometer. This may explain the differences in measured 
systematic errors between the various types of joints. For example, the small systematic error in 
DIP V may be related to the relatively flat shape of the articular surfaces. Although systematic 
errors differ between the different joint shapes, this may be of less relevance in future clinical 
trials, in which progression is being measured and the smallest detectable difference (SDD) would 
be more important than the systematic error. 
 
Applicability of the automatic quantification method in clinical trials 
In clinical trials progressive reduction in JSW from a patient given baseline would be assessed by 
the automated program. We used a micrometer determined baseline of 1.1 mm, based on results 
of a previous study in which JSW values were between 1.6 mm (MCP healthy subjects) and 0.6 
mm (DIP OA patients)(26).   
Angwin et al. studied the sensitivity and reliability of mean computerized JSW measurements in 
standard clinical hand radiographs of healthy subjects and the effect of hand position and joint 
angulation on measurement reliability(19). They found that a change > 0.11 mm in JSW in an 
individual joint would represent an actual physical change in JSW (outside the 95% confidence 
interval), and that the smallest detectable change decreased to 0.05mm when different 
measurements across fingers of a single subject where averaged. In our study we also investigated 
the influence of joint location, joint shape and JSW size on the smallest detectable difference. The 
results of our study show that the smallest detectable change in JSW of our quantification method 
ranges from 0.012mm to 0.047mm per individual finger joint. The differences in outcomes 
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between the two studies might be explained by the different measurements methods used, or by 
the fact that Angwin et al. used digitalized images captured from standard film radiographs.  
 
In order to assess the applicability of the quantification method in future clinical trials, an 
indication of the expected rate of decline in JSW in the normal and OA population is needed. 
Pfeil et al (22-24) published a set of normative age-related and gender-specific JSW data in 869 
normal (non-OA) patients. Those results show that in the normal population, aged between 20 
and 80 years, there is a decrease in JSW between 0.1 and 0.2 mm every 20 years, depending on age 
and type of finger joint. This corresponds to an annual decrease between 0.005mm and 0.01mm. 
Our SDD results show that normal JSW reduction in non-OA patients could thus be detected in 
the DIP joints within two to four years, especially when measurements of different fingers and 
hands are averaged. The rate of JSW decline in hand OA patients is not known exactly, but a 
recently published prospective observational study showed that the semi-quantitative OARSI atlas 
scoring method was able to detect JSN progression after two years in 33 (19.2%) of 172 hand OA 
patients (30). Because rapid decrease of JSW is one of the main factors in hand OA, it is to be 
expected that the first signs of progression can be detected within one or two years with this 
automatic quantification method.  
 
A few limitations apply to our study. The influence of finger joint flexion and extension in the 
measurement of JSW was not tested. Angwin et al (19) have demonstrated that this influences 
JSW measurements slightly. However, in contrast to rheumatoid arthritis, deformity of the hand 
joints is not as marked in OA. Only in a late stage of OA, full extension of the hand is limited by 
joint destruction. As stated by Angwin et al, the value of a sensitive measurement method lies in 
the detection of early progression in order to test possible benefits of newly developed methods to 
arrest or slow down the OA process. Therefore, it is expected that limited finger extension will not 
play a significant role in future OA research. 
It is possible that in vivo both systematic error and SDD may be different from the values that we 
found in the cadaver derived bone experiment, since the actual radiographic contrast between 
bone, cartilage and synovial fluid is lower than between bone and air in our experiment. However, 
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conducting a study in vivo in humans using induced progression of JSN is practically and 
ethically impossible.   
In hand OA research, progression of JSN is one of the most important parameters. The results of 
this study show that, dependent on the type of joint, a decrease in JSW of 0.01 to 0.05 mm can be 
detected with our automatic quantification method. It is to be expected that with this method the 
first signs of OA progression can be detected within one or two years, making it a sensitive tool in 
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Abstract 
The objective of this study was to identify risk factors for knee osteoarthritis (OA) development in 
a young to middle-aged population with sub-acute knee complaints. This, in order to define high 
risk patients who may benefit from early preventive or future disease modifying therapies. Knee 
OA development visible on radiographs and MR in 319 patients (mean age 41.5 years) 10 years 
after sub-acute knee complaints and subjective knee function (KOOS score) was studied. 
Associations between OA development and age, gender, activity level, BMI, meniscal or anterior 
cruciate ligament (ACL) lesions, OA in first-degree relatives and radiographic hand OA were 
determined using multivariable logistic regression analysis. OA on radiographs and MR in the 
TFC is associated with increased age (OR: 1.10, 95 % 1.04–1.16 and OR: 1.07, 95 % 1.02–1.13). 
TFC OA on radiographs only is associated with ACL and/or meniscal lesions (OR: 5.01, 95% CI 
2.14–11.73), presence of hand OA (OR: 4.69, 95 % 1.35–16.32) and higher Tegner activity scores 
at baseline before the complaints (OR: 1.20, 95% CI 1.01–1.43). The presence of OA in the TFC 
diagnosed only on MRI is associated with a family history of OA (OR: 2.44, 95% CI 1.18–5.06) 
and a higher BMI (OR: 1.13, 95% CI 1.04–1.23). OA in the PFC diagnosed on both radiographs 
and MR is associated with an increased age (OR: 1.06, 95% CI 1.02–1.12 and OR: 1.05, 95% CI 
1.00–1.09). PFC OA diagnosed on radiographs only is associated with a higher BMI (OR: 1.12, 
95% CI 1.02–1.22). The presence of OA in the PFC diagnosed on MR only is associated with the 
presence of hand OA (OR: 3.39, 95% CI 1.10–10.50). Compared to normal reference values, the 
study population had significantly lower KOOS scores in the different subscales. These results 
show that knee OA development in young to middle aged patients with a history of sub-acute 
knee complaints is associated with the presence of known risk factors for knee OA. OA is already 
visible on radiographs and MRI after 10 years. These high risk patients may benefit from adequate 
OA management early in life. 
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Introduction  
Osteoarthritis (OA) is a multi-factorial disease and predominantly involves the middle aged and 
older population (1). Risk factors for the development of OA are mechanical forces including 
trauma, age, female gender, family history of OA, obesity, morphologic changes and OA 
localization in another joint (2–7). To date no effective disease modifying medical therapy is 
available (8). 
Knee OA is one of the main causes of walking-related disability in older adults (7). In some 
patients knee OA develops after knee injury (9), whereas in other patients knee OA develops in a 
more generalized way without specific trauma, affecting multiple other joints. It has been 
suggested that these two forms of OA cannot be seen as distinct from each other and that genetic 
predisposition may play a role in the development of knee OA after trauma (4, 5, 10–17). Studies 
investigating factors involved in OA development are usually performed in older populations 
with mean ages ranging from 50 to 80 years (5, 18–20). 
The objective of the current study was to determine which risk factors could be identified for knee 
OA development in a specific population aged 24 to 55 years with a history of sub-acute knee 
complaints. Identifying these specific risk-factors may help to distinguish high-risk knee patients 
for the development of knee OA. Identifying these risk-factors in young patients with knee 
complaints could be of clinical importance. It is likely that these high risk patients will benefit 
from slowing down or even stopping the OA process by early preventive exercise therapy or 
eventually disease modifying medication (8, 21–23). 
We investigated the following OA risk factors: anterior cruciate ligament (ACL) and / or meniscal 
lesions, age, female gender, body mass index (BMI), activity level before knee complaints, a family 
history of OA and the presence of hand OA. 
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Materials and methods 
Study design 
We studied a group of patients with a mean age of 41.5 years (SD 7.6) with a history of sub-acute 
knee complaints 10 years ago who had been the subject of a previous study of possible internal 
derangement of the knee (24). Subjects who were invited for this current study had participated 
between March 1997 and October 1999 in a prospective observational cohort study of 855 sub-
acute knee patients to evaluate the cost effectiveness of magnetic resonance (MR) relative to 
diagnostic arthroscopy in patients with sub-acute knee complaints (24). Sub-acute knee 
complaints were defined as persistent knee complaints e.g. pain, swelling and instability lasting 
for more than four weeks. Patients between 15 and 45 years of age were included. Exclusion 
criteria were: knee complaints lasting less than four weeks, clinical symptoms of a locked knee, 
known inflammatory diseases such as rheumatoid arthritis, severe radiographic OA (Kellgren 
grade 4) and a history of knee surgery (24). After inclusion in the initial study all patients 
underwent 0.5 T MR imaging. Patients with a clinical suspicion of structural damage underwent 
arthroscopy if the MR result also showed structural defects needing surgical treatment. Patients 
with a clinical suspicion of structural damage, but no such damage visible on MR imaging were 
randomly assigned to a conservatively treated group and a diagnostic arthroscopy group. Knee 
function outcomes between the conservative and arthroscopy group were evaluated after three 
and six months follow up (24). Therefore, all patients received usual orthopaedic care while some 
patients underwent an additional diagnostic arthroscopy besides knee MR imaging. This study 
design was chosen for the initial study to allow evaluation of effectiveness and costs of MR 
imaging compared to diagnostic arthroscopy(24). All 855 subjects were invited by mail and 
telephone to participate in the current study and 319 patients (37 %) could ultimately be included 
(Fig. 1). 
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Bony features of knee OA can be detected on radiographs. MR imaging adds information about 
soft tissues (e.g. ligamentous structures, synovium) which makes it possible to assess the knee as a 
whole organ (25, 26). Although the use of MR imaging is gaining more interest in daily clinical 
practice and in the field of OA research, conventional knee radiographs are still considered to be 
the standard in imaging knee OA. in both clinical and research settings (25). Therefore, in this 
study both radiographs and MR were used to determine knee OA development. To assess the 
presence of radiographic knee OA and/or knee OA on MR, standardized knee radiographs and 
knee MR scans were made of the initially affected knee. To determine if the ACL or menisci had 
been structurally damaged, both the knee MR images made 10 years ago and the recent follow-up 
MR data were used. To assess the presence of hand OA, routine hand radiographs were made. 
Questionnaires were used to obtain information about the body mass index (BMI), knee trauma 
and the presence of OA in first degree relatives. A family history was considered to be present 
when at least one first degree relative had OA. The Tegner activity scale was used to assess activity 
levels before the start of the knee complaints (27). The KOOS knee function questionnaire was 
used to determine subjective knee function after 10 years (28). 
 
Imaging and assessment of knee OA features   
Knee Radiographs 
Ten years ago knee radiographs were made to identify signs of knee OA. During follow-up visit 
after 10 years standardized weight bearing posterior-anterior knee radiographs in a semi-flexed 
position and lateral radiographs of the knee were made. Knee radiographs of the initially affected 
knee were scored for the presence and severity of OA using the 0–4 Kellgren and Lawrence (KL) 
scoring system (29). Radiographic knee OA was considered to be present in patients with a KL 
score of 2 or higher. Joint space narrowing (JSN) and osteophyte formation in the patellofemoral 
compartment (PFC) were scored on the same basis of severity (0–3) compared to the skyline view 
radiographs described in the OARSI atlas (30). All radiographs were scored in consensus by an 
experienced musculoskeletal radiologist with over 30 years of experience (IW) and a research 
fellow (KH). The outcome scores were used in a binary fashion (absent-present) for further 
analysis. 
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Knee MR imaging 
Ten years ago 0.5 T knee MR (Gyroscan T5; Philips Medical Systems, Best, the Netherlands) scans 
were evaluated on the presence of ACL and / or meniscal lesions by one of six radiologists 
involved in the initial study with at least 4 years of experience with musculoskeletal MR imaging 
(24). 
During follow-up visit, 3.0 T MR examinations (Achieva 3 T, Philips Medical Systems, Best, the 
Netherlands) were performed of the initially affected knee, blinded for patient characteristics and 
scored in consensus by two experienced musculoskeletal radiologists (JLB, IW) each with over 20 
years of MR imaging experience and a research fellow (KH). Scored items were absence or 
presence of ACL and / or meniscal tears, diffuse and focal cartilaginous defects, osteophytes, bone 
marrow edema-like abnormalities (BME), meniscal subluxations and subchondral cysts with 
values from absent to severe (0–3) using the validated KOSS scoring system (31). Cartilage 
lesions, osteophyte formation, BME and subchrondal cysts were scored in four compartments of 
the TFC and in five compartments of the PFC. For further analysis the outcome scores were used 
in a binary fashion (absent-present). To assess the presence of knee OA on MRI a Delphi exercise 
based definition of OA on MRI was used (26). Tibiofemoral OA was considered to be present 
when both definite osteophyte formation and full thickness cartilage loss are present, or when 
definite osteophyte formation or full thickness cartilage loss are present and two or more of the 
following features: 1) BME or cyst not associated with meniscal or ligamentous attachments; 2) 
meniscal subluxation, maceration or degenerative (horizontal) tear; 3) partial thickness cartilage 
loss (where full thickness loss is not present). Since bone attrition is not a specific item described 
in the KOSS scoring system, bone attrition could not be used as an OA scoring. Patellofemoral 
OA detected on MR images is considered to be present if a definite osteophyte and partial or full 
thickness cartilage loss involving the patella and/or anterior femur are found (26). An osteophyte 
with a KOSS score of 2 or higher was considered to be definite. 
 
Radiographic OA assessment of the hand 
Hand radiographs 
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During follow-up visit hand template assisted standardized PA radiographs were taken of both 
hands and scored on a scale of 0–3 for joint space narrowing in the fingers joints (H-JSN) and 
osteophyte formation, using the OARSI atlas (30). All radiographs were scored in consensus by an 
experienced musculoskeletal radiologist with over 30 years of experience (IW) and a research 
fellow (KH). These outcome scores were used in a binary fashion (absent-present) for further 
analysis. Because the study group comprised young to middle-aged patients, we expected to find 
only a small number of hand joints affected by OA (32). Therefore, we additionally employed an 
automatic joint space width (JSW) quantification method to detect subtle differences in finger 




For data analysis, SPSS version 20 was used. Chi-square tests and independent T- tests were used 
to compare the population characteristics of the follow-up population and the non-follow-up 
group. To compare knee function score outcomes and the presence of radiographic knee OA of 
the study population to normal population reference values (32, 35) the T-test and Chi square test 
were used. According to their presence or absence, both MR and radiographic detectable knee OA 
were categorized in a binary fashion. Binary logistic regression analysis was used to determine 
associations between radiographic knee OA or knee OA on MRI and the following independent 
variables: age, gender, a family history of OA, BMI, Tegner activity level before complaints, ACL 
and/or meniscal lesions, radiographic hand OA, and the mean JSW of the finger joints. All 
covariates were used in one model. The presence of knee OA in the TFC and PFC defined on 
radiographs and MR images were used as dependent variables. Odds ratios (OR) and 95 % 
confidence intervals were determined and adjusted for all variables. To determine associations 
between KOOS knee function outcomes and age, gender, BMI, activity level before complaints, 
ACL and/or meniscal lesions and radiographic knee OA or knee OA on MRI a multivariate 
analysis of covariance model was used. Effect size and 95 % confidence intervals were determined 





A total of 319 patients were included in the present study. The mean age of the study population 
was 41.5 years (range 24-55y, SD 7.6). The percentage women was 33% (106). The mean BMI was 
26.1 (SD 3.8). None of the included subjects had experienced a major knee trauma in the last 
decade. A family history of OA was present in 70 patients (22%). ACL and/or meniscal lesions 
were present in 188 patients (57 %), this was an increase of 20 patients (6%) relative to the start of 
the study. A total of 212 (67%) patients underwent an arthroscopy or other invasive procedure in 
the affected knee.  Forty-nine (56%) of the 87 patients who returned the follow-up invitation 
letter, but refused to participate in the study had knee complaints. The main reason not to  
participate in the current study was a lack of time. At baseline there were no differences in 
radiographic knee OA severity between those who chose to participate in this current study and 
those who were non-responders or declined participation (P >>0.05). 
 
Presence of knee OA on the follow-up radiographs 
Radiographic tibiofemoral knee OA (KL 2) was present in 74 patients (23%) at follow-up. The 
two patients with a K&L score of 2 at baseline both showed OA progression to a K&L score of 4.  
The remaining 18 patients had a K&L score of 1 at baseline, seven of these remained K&L 1, in the 
other 11 patients there was an increase of at least one grade in the K&L score after 10 years (5 
patients K&L 2; 6 patients K&L 3) (Table 1). Patellofemoral JSN and/or osteophytes were present 
in 71 (22%) patients at follow-up. Seventy-one patients  developed JSN and osteophytes in the 
PFC after 10 years. In seven of these (10%) JSN was also present at baseline while the other 54 
patients had developed new lesions. 
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Table 1  
Presence of radiographic Knee OA at baseline and follow-up 
Number of subjects with radiographic knee OA scored with the Kellgren and Lawrence (K&L) scoring 
system at baseline and after 10 years follow-up. 
 
 
Normal values of the prevalence of radiographic knee OA are only available for men and women 
aged 45 years and older (32). In the study population 109 (34 %) patients were aged 45 years or 
older. Only 3 patients were aged 55 years or older, due to the small sample size OA prevalence 
could not be compared to normal reference data. In both men and women aged between 45 and 
49 years at follow-up the prevalence of knee OA was higher than in the normal population (34.9 
% vs. 9.4 % and 22.7 % vs. 14.2 %), this difference was statistically significant (p < 0.001) only in 
men. Compared to the prevalence of knee OA in the normal population, in both men and women 
aged between 50 and 54 years the prevalence of knee OA was statistically significant higher (40 % 
vs. 13.5 % and 42.1 % and 18.3 %) (p < 0.001 and p = 0.01). 
There were no differences in the radiographic knee OA development between patients randomly 
assigned to the conservatively treated group or to the diagnostic arthroscopy group. 
Presence of knee OA on  follow-up MR images 
Knee OA on MR was present in the TFC in 73 patients (23 %) and in the PFC in 78 patients (25 
%). OA progression on MR imaging could not be assessed because different types of scanners (0.5 
T vs. 3.0 T) and different scoring methods were used at baseline and at follow-up. 
After 10 years follow-up 
K&L score 
0 1 2 3 4 
 0 13 225 37 11 13 
 1 0 7 5 6 0 
Baseline 2 0 0 0 0 2 
 3 0 0 0 0 0 
 4 0 0 0 0 0 
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Prevalence of radiographic hand OA  
In 8 of the 319 included patients no hand radiographs were made due to late withdrawal by 
patients. Seventeen (5.3 %) subjects had signs of hand OA according to the OARSI atlas scoring 
method. A total of 56 joints had mild to moderate signs of hand OA (H-JSN or osteophyte grade 
1–2). There were no patients with severe hand OA (grade 3). Most affected were the DIP joints 
(29; 52 %) and the CMC I joints (25; 45 %). In the majority (50 joints; 89 %) of the joints affected 
with OA, osteophytes as well as H-JSN were present. Few joints had isolated H-JSN (two CMC I 
and four DIP joints). In patients with hand OA according to the OARSI atlas there was a trend 
towards a smaller JSW in all measured finger joints; the mean difference in JSW for the MCP, PIP 
and DIP joints were 0.08 mm, 0.02 mm and 0.05 mm respectively, however none these differences 
were statistically significant. 
 
Factors associated with radiographic knee OA or  knee OA on MRI 
Associations between risk factors and the presence of knee OA are described in Tables 2, 3, 4 and 
5. 
Age 
Increased age was associated with the presence of radiographic knee OA in the TFC (radiographic 
and MR) and PFC (radiographic and MR)  
Gender 
There were no significant differences between men and women in the presence of knee OA. 
BMI 
A higher BMI was associated with the presence of OA in the PFC (radiographs only), and with the 
presence of OA in the TFC (MR only).  
ACL and/or meniscal lesions 
ACL and/or meniscal lesions were associated with the presence of OA in the TFC (radiographs 
and MR).  
Familial OA  
A family history of OA was associated with the presence of OA in the TFC (MR only). 
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Hand OA 
The presence of radiographic hand OA was associated with the presence of OA in the TFC 
(radiographs only) and with the presence of OA in the PFC (MR only).   
Tegner activity levels 
Higher Tegner activity levels at baseline were associated with an increased risk of developing 





Table 2 Radiographic findings tibiofemoral compartment  
Associations between radiographic knee OA defined as a Kellgren and Lawrence score (K&L) of 2 in the TFC and the listed independent variables. Binary 
logistic regression analysis was used. Outcomes were adjusted for all independent variables. 
* Statistically significant difference, adjusted for all variables in table 
Abbreviations: TFC= tibiofemoral compartment, K&L= Kellgren and Lawrence score, OR= odds ratio, 95% CI = 95% confidence interval, SD= standard 
deviation, ACL=anterior cruciate ligament 












Mean age in yrs (SD) 40 (7.5) 45 (7.0) 1.09 1.05-1.13 1.10 1.04-1.16 <0.001* 
Sex, number of women (%) 82 (34%) 24 (32%) 0.95 0.55-1.66 2.78 0.93-8.25 0.07 
BMI, kg/m2 (SD) 25.8 (3.9) 26.9 (3.4) 1.07 1.00-1.15 1.07 0.98-1.18 0.15 
ACL or meniscal Lesions (%) 129 (53%) 59 (80%) 3.54 1.90-6.57 5.01 2.14-11.73 <0.001* 
Presence of familial OA (%) 52 (22%) 16 (24%) 1.07 0.56-2.02 1.27 0.58-2.80 0.56 
Tegner activity score baseline (SD) 5.9(2.4) 5.9 (2.3) 1.00 0.90-1.12 1.20 1.01-1.43 0.04* 
Radiographic hand OA (%) 8 (3%) 9 (12%) 4.09 1.52-11.01 4.69 1.35-16.32 0.02* 
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Table 3 Radiographic findings patellofemoral compartment  
Associations between radiographic knee OA defined as a Kellgren and Lawrence score (K&L) of 2 in the PFC and the listed independent variables. 
Binary logistic regression analysis was used. Outcomes were adjusted for all independent variables. 
Independent variables 
No JSN or 
Osteophytes 









95% CI  
Adjusted 
P-value 
Mean age in yrs (SD) 41 (7.5) 45 (7.2) 1.08 1.04-1.12 1,06 1,02-1,12 0,01* 
Sex, number of women (%) 79 (36%) 18 (26%) 0.61 0.33-1.11 0,57 0,21-1,57 0,27 
BMI, kg/m2 (SD) 25.6 (3.7) 27.3 (3.8) 1.12 1.04-1.20 1,12 1,02-1,22 0,01* 
ACL or meniscal Lesions (%) 122 (56%) 49 (69%) 1.79 1.01-3.16 1,95 0,96-3,99 0,07 
Presence of familial OA (%) 49 (24%) 14 (21%) 0.82 0.42-1.60 1,02 0,48-2,18 0,97 
Tegner activity score baseline (SD) 5.9 (2.3) 5.7 (2.5) 0.96 0.85-1.07 1,03 0,89-1,21 0,67 
Radiographic hand OA (%) 8 (4%) 8 (11%) 3.35 1.21-9.28 2,59 0,84-7,96 0,10 
* Statistically significant difference, adjusted for all variables in table Abbreviations: PFC= patellofemoral compartment, K&L= Kellgren and Lawrence 
score, OR= odds ratio, 95% CI= 95% confidence interval, SD= standard deviation, ACL=anterior cruciate ligament 
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Table 4 MRI Findings tibiofemoral compartment 
Associations between knee OA on MRI defined by the Delphi criteria in the TFC and the listed independent variables. Binary logistic regression analysis 
was used. Outcomes were adjusted for all independent variables. 
* Statistically significant difference, adjusted for all variables in table Abbreviations: TFC= tibiofemoral compartment, K&L= Kellgren and Lawrence score, 
OR= odds ratio, 95% CI= 95% confidence interval, SD= standard deviation, ACL=anterior cruciate ligament 
 
No MRI OA according 
to Delphi  criteria 
MRI OA according 








95% CI  
Adjusted 
P-value 
Mean age in yrs (SD) 41 (7.7) 44 (6.9) 1.06 1.03-1.10 1.07 1.02-1.13 <0.001* 
Sex, number of women 
(%) 
89 (40%) 13 (17%) 0.31 0.16-0.60 0.45 0.161.28 0.13 
BMI, kg/m2 (SD) 25.6 (3.8) 27.3 (3.7) 1.11 1.04-1.20 1.13 1.04-1.23 0.01* 
ACL or meniscal Lesi-
ons (%) 
118 (53%) 54 (72%) 2.25 1.27-3.97 2.02 1.00-4.08 0.05 
Presence of familial 
OA (%) 
44 (21%) 20 (29%) 1.53 0.83-2.84 2.44 1.18-5.06 0.02* 
Tegner activity score 
baseline (SD) 
5.8 (2.4) 6.1 (2.3) 1.05 0.94-1.18 1.12 0.96-1.30 0.16 
Radiographic hand OA 
(%) 
9 (4%) 7 (9%) 2.41 0.87-6.73 1.69 0.52-5.47 0.38 
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Table 5 MRI Findings patellofemoral compartment 
Associations between knee OA on MRI defined by the Delphi criteria in the PFC and the listed independent variables. Binary logistic regression analysis 
was used. Outcomes were adjusted for all independent variables..  
 
No MRI OA according 
to Delphi  criteria 
MRI OA according 








95% CI  
Adjusted 
P-value 
Mean age in yrs (SD) 41 (7.3) 43 (8.2) 1.05 1.01-1.09 1.05 1.00-1.09 0.03* 
Sex, number of wo-
men (%) 
77 (35%) 25 (32%) 0.87 0.50-1.50 0.77 0.31-1.93 0.58 
BMI, kg/m2 (SD) 25.7 (3.6) 26.9 (4.3) 1.08 1.01-1.16 1.05 0.97-1.13 0.22 
ACL or meniscal Lesi-
ons (%) 
130 (60%) 42 (54%) 0.79 0.47-1.33 0.71 0.38-1.30 0.26 
Presence of familial 
OA (%) 
43 (21%) 21 (28%) 1.45 0.79-2.65 1.78 0.92-3.43 0.09 
Tegner activity score 
baseline (SD) 
5.9 (2.3) 5.7 (2.5) 0.97 0.86-1.08 1.04 0.91-1.20 0.56 
Radiographic hand 
OA (%) 
6 (3%) 10 (13%) 5.17 1.81-14.76 3.39 1.10-10.50 0.03* 
* Statistically significant difference, adjusted for all variables in table Abbreviations: PFC= patellofemoral compartment, K&L= Kellgren and Lawrence 
score, OR= odds ratio, 95% CI= 95% confidence interval, SD= standard deviation, ACL=anterior cruciate ligament 
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Additional diagnostic arthroscopy in randomization group 
There were no differences in radiographic knee OA or MR knee OA development between 
patients randomly assigned to the conservative treated group or to the diagnostic arthroscopy 
group. 
 
Subjective Knee function after 10 years 
KOOS knee function outcomes compared to normal reference data (35) are shown in Table 6. 
Due to the small sample size p-values for the age group above 55 years could not be determined. 
Generally, our study population had lower KOOS scores compared to the normal reference 
values. In the subscales Sports& Recreation and Quality of Life these difference were significant in 
all groups. Dependent on age and gender the subscales Pain, Symptoms and ADL were also 
significant lower in our study population compared to the normal reference values. 
Lower KOOS scores in all subscales were associated with an increased BMI (Effect size reaching 
from 0.024- 0.064). TFC OA according to the Delphi criteria was associated with lower outcomes 
in the subscales Sports and Recreation and Quality of life (Effect size 0.027 and 0.021). The 
presence of JSN and osteophytes in the PFC was associated with lower Quality of life scores 
(Effect size 0.017). Higher Tegner Activity scores at baseline were associated with higher scores in 
the subscales Pain and Sports and recreation (Effect size 0.018 and 0.019). A higher age was 
associated with lower scores in the subscales ADL and Pain (Effect size 0.018 and 0.048). The 
presence of ACL and/or meniscal lesions was associated with lower Symptoms scores (Effect size 
0.019). There were no differences in KOOS outcomes between patients randomly assigned to the 
conservatively treated group or to the diagnostic arthroscopy group. 
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Table 6  
KOOS knee function outcomes 10 years after sub-acute knee complaints 
Age and gender specific differences in KOOS knee function subscales scores compared between the study population outcomes and reference data published by 
Paradowski et al. (51)  
  18–34y 35–54y 55–74y 
  male female male female male female 
 KOOS subscales N Mean (SD) p N Mean (SD) p N Mean (SD) p N Mean (SD) p N Mean (SD) N Mean (SD) 
Studypopulation PAIN 31 79.9(17.9) 24 86.3(13.4) 162 82.9(18.1) 76 75.2(25.8) 2 36.1(35.4) 2 87.5(17.7) 








88 87.7(17.4) 85 78.6(25.5) 
Studypopulation SYMPTOMS 31 73.2(20.6) 25 79.1(17.8) 163 82.0(16.8) 76 75.7(19.6) 2 30.4(27.8) 2 89.3(15.2) 








88 88.4(17.3) 85 77.1(24.8) 
Studypopulation ADL 31 87.8(15.5) 24 92.8 (9.7) 163 86.9(16.9) 74 80.3(23.7) 1 11.8 (-) 2 89.0(15.6) 








88 86.3(18.8) 85 77.4(26.2) 
Studypopulation SPORT&REC 31 62.7(27.9) 24 62.9(25.4) 163 64.8(28.6) 76 53.0(35.3) 2 20.0(28.3) 1 100.0 (-) 








87 72.6(29.9) 84 61.0(36.9) 
Studypopulation QOL 31 59.5(20.3) 25 67.0(17.5) 162 63.5(22.0) 76 59.2(28.7) 2 21.9(30.9) 2 84.4(13.3) 








88 78.9(25.4) 85 68.6(31.4) 
* Statistically significant difference P-values were derived using Chi-square testing Abbreviations: ADL= Function (Activities) in daily living  SPORT&REC  = 
Function in sport and recreation, QOL = Knee related Quality of Life  
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Discussion  
The results of our study show that in this specific young to middle-aged population with a history 
of sub-acute knee complaints, several factors are associated with the development of knee OA on 
radiographs and/or MR over a 10 year period. OA on radiographs and MR in the TFC is 
associated with age. TFC OA on radiographs is associated with ACL and/or meniscal lesions, the 
presence of hand OA and higher Tegner activity scores at baseline before the complaints. The 
presence of OA in the TFC diagnosed only on MRI is associated with a family history of OA and a 
higher BMI. OA in the PFC diagnosed with both radiographs and MR is associated with an 
increased age. PFC OA diagnosed on radiographs only is associated with a higher BMI. The 
presence of OA in the PFC diagnosed with MR is associated with the presence of hand OA. 
In contrast to OA development in the TFC, ACL and /or meniscal lesions are not associated with 
the development of knee OA in the PFC. This supports the hypothesis that underlying 
biomechanical factors related to knee OA development in the TFC and the PFC may be different 
(37-39). Lesions of the menisci and ACL may disturb adequate mechanical loading in the TFC 
whereas patellar misalignment causes disturbance of patella movements in the femoral trochlea 
(40, 41). On the other hand, our results indicate that besides mechanical factors other factors are 
associated with, both TFC and PFC OA development (e.g. BMI, hand OA). 
Several publications have shown that the development of knee OA is related to the presence of 
hand OA (10, 13, 16, 42), the results of our study confirm this relationship in a young middle-
aged population with knee complaints 10 years ago for both radiographic OA in the TFC and OA 
on MRI in the PFC. 
An association between the development of knee OA and a family history of OA (17, 42, 43), has 
been described, whereas others did not find such a relationship (20). Our results show that in this 
young to middle-aged population a family history of OA is associated with OA on MRI in the 
TFC. 
Age is related to radiographic knee OA and knee OA on MRI in both the TFC and the PFC. A 
higher BMI is associated with knee OA on MRI in the TFC and radiographic knee OA in the PFC. 
These relationships have been described in studies which investigated risk factors for the 
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development of knee OA in older populations (2, 5, 32, 44–49). Our results show that this effect is 
already visible at a relatively young age. 
We found no gender-related differences in the development of radiographic knee OA or knee OA 
on MRI. These results are in contrast to most publications which reported an increased risk of 
developing knee OA in women compared to men (5, 32, 50). This may be explained by the fact 
that the female participants in the present study were mostly pre-menopausal, in contrast to older 
and post-menopausal women in the other publications. 
Higher Tegner activity levels before the start of the knee complaints at baseline are associated with 
radiographic TFC OA development. This is in agreement with previous published data, in which 
the relationships between sports and TFC OA development is described (36). 
Compared to reference data published by Paradowski et al. (35) our study population had lower 
KOOS knee function scores than the general population. This difference seems to be of clinical 
importance in all KOOS subscales except for ADL since the mean outcome scores differ more 
than 10 points, which is considered to be clinically relevant (28). Therefore, it can be concluded 
that patients with sub-acute knee complaints have an increased risk of poorer subjective knee 
functioning after 10 years. Our results also show that radiographic OA and OA on MRI are only 
partly related to poorer subjective knee function (only with respect to the subscales Sports & 
recreation and Quality of life), this is in agreement with previous published data on the 
relationship between radiographic and clinical OA (37). BMI, age, activity level, radiographic PFC 
OA and TFC OA on MRI are all associated with subjective poorer knee functions, however, non 
of these associations appear to be strong (effect sizes all smaller than 0.1). 
Bony features of knee OA are visible on knee radiographs and MR imaging makes it possible to 
assess the knee as a whole organ adding information about soft tissues (e.g. ligamentous 
structures, synovium) (25). Several risk factors have a statistically significant association with both 
X-ray and MRI OA development (Age and ACL or meniscal lesions). Some factors did not reach 
statistical significance with OA development on both modalities, although OR’s of both MRI and 
X ray outcomes gave a same association. The latter may be due to the fact that some of the groups 
were small (potential type II effect) (Tables 2, 3, 4 and 5). Although MR imaging is widely held to 
be more sensitive in detecting OA (51) we found a higher number of patients with radiographic 
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knee OA than knee OA at MRI. This is because in order to meet the Delphi criteria for OA at MRI 
not only osteophytes and cartilage lesions have to be present but also several other criteria linked 
to soft tissue injuries have to be present as well. In fact, there are significantly more patients with 
cartilage lesions and osteophytes detected on MR than on radiographs, mainly because small 
defects are easier to detect on MR imaging than on radiographs. 
To date no disease modifying medication is available, however several drugs are in development 
which may be essential in future prevention of joint replacement surgery (52). The current study 
shows that in young to middle aged patients with an episode of sub-acute knee complaints risk 
profiling for OA can identify patients who have an increased risk of developing OA within 10 
years. This may open the road to preventive or disease modifying therapies, thus preventing total 
knee replacement later in life 
Some limitations to our study should be mentioned. Due to technical limitations, the JSW of 
finger joints in the first ray could not be measured with the automatic quantification method, 
while single most radiographic hand OA features assessed using the OARSI atlas were present in 
the CMC I joint. A family history of OA was self-reported using a questionnaire. There is a 
reasonable chance that only relatives with symptomatic OA were mentioned in the forms, which 
may have biased our estimations. BMI was not determined at baseline, therefore only follow-up 
data could be used to determine associations between an increased BMI and knee OA 
development. Another limitation is a comparison could not be made on the prevalence of knee 
radiographic changes in people without non-acute knees symptoms a decade ago. Reference data 
concerning the prevalence of radiographic knee OA in the general population aged < 45 years are 
not available. When we compare the prevalence of knee OA in the normal population older than 
45 years (32), our patients appear to be more often affected with knee OA compared to these 
normal values. 
In conclusion, the presence of certain known risk factors in young to middle aged patients with an 
episode of sub-acute knee complaints a decade ago are associated with the development of knee 
OA visible on radiographs and MR imaging. These patients also report poorer subjective knee 
function compared to normal reference values. Knee radiographs and MR images combined with 
assessment of the presence of these risk factors can be used to identify high risk patients who may 
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To determine potential differences in 10 year clinical outcome of surgically and conservatively 
treated traumatic meniscal lesions in patients without locking.  
Methods 
We performed a 10-year follow-up study of 118 patients (mean age 32 years SD 7.8) with 
traumatic meniscal tears without locking complaints. Clinical outcome measures of surgically and 
conservatively treated patients were compared using the Noyes and KOOS knee questionnaires. 
Results  
There were no differences in short- and long-term Noyes scores and long-term cross-sectional 
KOOS Pain, Symptoms, ADL and Quality of life outcomes.  KOOS Sports and Recreation 
outcomes were significantly better in surgically treated patients (19.2 points, 95% CI 1.5; 36.8, 
p=0.033). Higher activity levels before the start of the complaints improved this effect.  
Conclusions 
Partial meniscectomy of traumatic meniscal tears may result in better Sports and Recreation 
related long-term clinical outcomes. This effect is positively associated with higher activity levels 
before injury. Future randomized controlled trials may elucidate the effect of surgical treatment of 
traumatic meniscal tears. 
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Introduction 
Meniscal tears are common injuries and are often treated by partial meniscectomy [1]. Figures 
from a database representing 9% of the U.S. population under 65 years of age showed that 387.833 
arthroscopic partial meniscectomies were performed between 2005 and 2011 [2].  
Recent studies have questioned the benefit of partial meniscectomy in patients with degenerative 
meniscal tears. [3]. A recently published trial showed that knee function outcomes in patients 
with degenerative meniscal tears after partial meniscectomy were not better compared to 
outcomes after sham surgery [4]. Whereas degenerative meniscal tears result from repetitive 
normal forces acting upon a worn down meniscus in the older population, traumatic meniscal 
tears are related to excessive force applied to a normal meniscus and are mainly present in the 
young to middle aged population [5]. 
Consensus based guidelines on the management of meniscal lesiosn exist [6] and long term 
follow-up clinical effects after meniscectomy have been studied [7;8]. However, no comparative 
studies between surgical and conservative management of traumatic meniscal tears have been 
performed [9]. Although it has been suggested that knee locking in patients with traumatic 
meniscal tears can be considered to be an indication for surgical treatment, controversy remains 
on the surgical management of traumatic meniscal lesions especially in those patients that present 
without locking symptoms [10].  
The aim of this study was to evaluate the long term (10 year) clinical effect of partial 
meniscectomy in patients with knee complaints lasting for more than four weeks without 
symptoms of knee locking. Ten year follow-up differences in knee function and symptoms scores 
were compared between surgically and non-surgically treated patients with traumatic meniscal 
tears. 
 
Patients and Methods 
Patient selection. 
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The clinical effect of meniscectomy in 118 knee patients with traumatic meniscal tears 10 years after 
knee complaints was determined. All 118 patients were part of a prospective cohort of  855 patients 
with knee complaints who participated in a study on the cost-effectiveness of 0.5T magnetic 
resonance (MR) imaging (Gyroscan T5; Philips Medical Systems, Best, the Netherlands) relative to 
diagnostic arthroscopy 10 years ago [11]. All 855 participants of the initial study were invited by 
mail and/or by telephone call for clinical knee function evaluation, knee radiographs and 3.0T MR 
imaging (Achieva 3T, Philips Medical Systems, Best, the Netherlands) at 10 year follow-up.  
Inclusion criteria for the original cohort study 10 years ago were knee complaints e.g. pain, 
swelling and instability lasting for more than four weeks. Exclusion criteria of the initial study 
were knee complaints lasting less than four weeks, clinical symptoms of a locked knee, known 
inflammatory diseases such as rheumatoid arthritis, moderate to severe radiographic knee OA 
and a history of knee surgery. At baseline MR images of the affected knee were made and all 855 
patients received regular orthopedic care [12].  
The study was approved by the Medical Ethics Review Boards of the three participating hospitals. 
Three hundred twenty-six patients were willing to participate in the current follow-up study (Fig. 
1). Written informed consent of each participant was obtained. The mean age of the 326 patients 
willing to participate in the follow-up study was higher (32 years; SD 7.7) than of the 529 non-
participants (31 years; SD 8.1).  There were no differences in  age, sex and traumatic meniscal 
tears without  anterior cruciate ligament (ACL) injury between the follow-up group and the non-
participants. Traumatic meniscal tears were more often surgically treated in the follow-up group 
[91 (77%)] than in the non-participants [118 (64%)], (p-value 0.016). Of the participants, patients 
without meniscal tears or those with an accompanying anterior cruciate ligament (ACL) ruptures 






Of the 118 patients with at least one traumatic meniscal tear and no ACL injury, 96 patients were 
treated by partial meniscectomy and 22 patients were treated conservatively. There was no 
difference in duration of the knee complaints before inclusion 10 years ago between surgically or 
conservatively treated patients (14 months (SD 28.2) vs. 13 months (SD 29.0), p-value 0.86) 
(Table 1).  
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Table 1 









Mean age at baseline (SD) 32.1 (6.4) 35.3 (7.0) 0.049* 
Number of women (%) 8 (36.4) 20 (20.8) 0.163 
Duration of the knee complaints before inclusion in months (SD) 12.9 (28.2) 14.1 (28.9) 0.860 
Tegner activity level before complaints (SD) 5.7 (2.1) 5.6 (2.3) 0.739 
Number of traumatic tears < 5mm (%) 6 (13.6) 3 (1.6) 0.002* 
Number of traumatic tears ≥ 5mm (%) 19 (43.2) 100 (52.4) 0.319 
Traumatic tear in both menisci (%) 3 (13.6) 8 (8.3) 0.428 
Traumatic tear in medial meniscus (%) 16 (72.7) 74 (77.1)  0.426 
Traumatic tear in lateral meniscus (%) 9 (40.9) 29 (30.2)  0.234 
*Statistically significant difference.  
The independent sample T-test, the Fisher’s Exact test and the Chi-square tests were used to compare means and proportions. 
 101 
A traumatic meniscal tear was defined as an intrameniscal signal intensity unequivocally 
extending to an articular surface visible on MR images after traumatic distortion of the knee, 
leading to complaints. 
 
Outcome Measures 
The clinical effect of management of the traumatic meniscal tears was determined by comparing 
Noyes knee Function and Symptoms scores and KOOS knee function scores of the 96 patients 
treated with partial meniscectomy and the 22 patients treated conservatively treatment. Noyes 
Symptoms scores range from 0 (serious symptoms) to 400 (no symptoms), Noyes Function scores 
range from 200 (poor function) to 550 (good function)[13]. Noyes knee scores were obtained at 
inclusion, 3 months, 6 months and 10 years follow-up. At 10 year follow-up knee function was also 
cross-sectionally scored using the KOOS questionnaire [14].  
A modified Lotysch classification system: a five-point grading scale for meniscal lesions 
(degenerative tears and traumatic tears, including buckethandle tears), was used to score the 
meniscal tears [15;16]. To determine radiographic knee OA development the Kellgren & Lawrence 
scoring system was used [17]. Knee OA was considered to be present in patients with a K&L score > 
1. Knee OA in the patellofemoral compartment was scored on joint space narrowing (JSN) and 
osteophyte formation similar to the skyline view radiographs described in the OARSI atlas [18] 
More detailed knee radiograph and MRI results of the 10 year follow-up cohort have been published 
earlier [19].  
The Tegner activity score before the start of symptoms at baseline 10 years ago was obtained 
retrospectively at the time of inclusion to determine the level of activity before the knee 
complaints. The Tegner activity scale  ranges from 10: high level competitive sports, through 0: 
not working due to knee problems [20]. Factors associated with functional outcomes after 
meniscectomy described in literature being gender, age and activity level [21] were also compared. 
 
Data Analysis  
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Longitudinal Linear Mixed Model analysis was used to compare the Noyes Function and 
Symptoms outcomes. Mancova analysis was used to compare the KOOS scores. All models 
included the variables sex, age, radiographic OA in the tibiofemoral end patellafemoral 
compartment, newly developed ACL lesions and Tegner activity level before the complaints. 
Effect estimates and 95% confidence intervals were determined. P-values < 0.05 were considered 
statistical significant.  
Results  
Management of Meniscal Tears  
In the first six months after inclusion, 91 of the 118 patients (77%) with traumatic meniscal tears 
were surgically treated, which is significantly higher than in the non-participant group with 
traumatic meniscal tears and no ACL lesions (64%, p = 0.014).  None of the patients were treated 
with meniscal repair. There were no differences in number of patients treated with meniscectomy 
between the three participating centers ( 27 (79%), 33 (89%) and 36 (77%), p = 0.319) 
Of the 11 patients with traumatic tears in both the medial and the lateral meniscus a partial 
meniscectomy was performed in both menisci in one patient, in four patients meniscectomy was 
performed in only one meniscus and three patients were conservatively treated. The surgical 
reports of the remaining three patients were not available for analysis.  
Between 6 months and 10 years follow-up, four of the initially conservatively treated patients with 
a traumatic tear underwent a partial meniscectomy. Ten year follow-up 3T MR images showed 
that three patients had developed new traumatic meniscal tears. Two of these three patients had 
been additionally treated with partial meniscectomy.  
The mean age in the meniscectomy group was higher (3.2 years) and there were no differences in 
number of women or activity levels . 
 
Knee function outcome scores 
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At inclusion the Noyes Function (360, SD 71 vs. 357 SD, 72) and Noyes Symptoms (268, SD 84 vs. 
276, SD 86) scores were not significantly different between the surgically and conservatively 
treated patient groups (p>>0.05). None of the Noyes Function outcomes scores were different in 
surgically or conservatively treated patients with traumatic meniscal tears (Table 2) (Fig 2). 
Uncorrected outcomes showed a significant positive effect of meniscectomy on long term Noyes 
Symptoms scores. However, after correction for sex, age, radiographic knee OA, newly developed 
ACL lesions and Tegner activity level before the complaints no differences were present (Table 2 
)(Fig 2). Long term Noyes Symptoms were mainly related to sex differences (women had lower 
scores) and activity level before the start of the knee complaints (higher Tegner activity scores 
were related to higher Symptoms scores).  
 
Figure 2 
Diagram showing the differences in Noyes knee Function and Symptoms scores 
between conservatively and surgically treated patients with traumatic meniscal tears. 
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Table 2   
Noyes scores throughout the 10 years follow-up 
  Short term follow-up Long term follow-up 
 
Treatment 
Baseline (n) 3 months (n) 6 months (n) Effect Estimate 
(95% CI) 




Conservative 360  (22) 391 (25) 421 (23) 460 (20) 
Noyes Function 
Meniscectomy 357 (96) 389 (86) 446 (85) 
22.2 (-11.7; 56.1) 0.20 
471 (88) 
1.3 (-16.1; 18.8) 0.88 
Conservative 268 (22) 322 (25) 339 (23) 309 (20) 
Noyes Symptoms 
Meniscectomy 276 (95) 324 (86) 355 (85) 
2.9 (-36.8; 42.7) 0.88 
360 (88) 
14.7 (-6.0; 35.3) 0.16 
 






In four of the five KOOS subscales there were no differences in outcome scores between surgically 
or conservatively treated patients with traumatic meniscal tears (Table 3) (Fig 3). In the KOOS 
subscale Sport & Recreations score there was a non-significant different higher mean score of 14.3 
points in patients with traumatic meniscal tears treated with partial meniscectomy. This effect 
increased to a statistically significant 19.2 points when corrected for gender, age, knee OA, newly 
developed ACL lesions and Tegner activity level before the complaints ( 95% CI 1.5; 36.8, p 
0.033). Higher Tegner activity scores had an additional positive effect on Sport & Recreations 
outcome scores after meniscectomy, whereas ACL lesions developed during follow-up and the 
presence of knee OA diminished this effect. 
 
Figure 3  
Knee injury and Osteoarthritis Outcome Score (KOOS ) after 10 years in patients with 




Table 3 KOOS outcomes 













1.2 (-9.1; 11.5) 0.814 5.1 (-6.6; 16.8) 0.387 




3.1 (-6.5; 12.7) 0.519 5.7 (-5.0; 16.4) 0.289 




0.7 (-10.5; 9.1) 0.880 1.8 (-9.0; 12.7) 0.738 




14.3 (-1.5; 30.0) 0.075 19.2 (1.5; 36.8) 0.033* 
Conservative 21 57.7 
Meniscectomy 89 
Quality of Life 
64.1 
6.3 (-6.6; 19.2) 0.311 9.6 (-3.2; 22.4) 0.141 
*Statistically significant difference.  
The independent T-test was used to compare the mean differences. MANCOVA was used to compare 10 year follow-up outcomes. 
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The mean activity levels before the start of the knee complaints were in the conservatively treated 
group 5.7 (SD 2.1) and in the meniscectomy group 5.6 (SD 2.3). The mean activity levels after 10 
years were in the conservatively treated group 5.2 (SD 2.3) and in the meniscectomy group 4.9 
(SD 2.4). These were not statistically significant differences. 
Discussion  
The results of this 10 year follow-up cohort study show that surgical treatment of traumatic 
meniscal tears in knee patients without locking complaints appears to have a positive effect on 
long term knee function outcomes compared to conservative treatment. Treatment with 
meniscectomy is related to better cross-sectional measured long term Sports and Recreation 
KOOS scores after 10 years, and this effect increases in patients with higher Tegner activity level 
scores before the complaints started. Although patients treated with meniscectomy also appear to 
be scoring better on long term follow-up Noyes Symptoms outcome scores, multivariate analysis 
shows that this effect is mainly related to gender differences (women scored worse than men).   
The effect of meniscectomy in patients with degenerative tears has been investigated in several 
randomized controlled trials [4;22;23],  but there is a void in the literature for the treatment of 
traumatic tears with no mechanical symptoms. The indication for surgical treatment is mainly 
based on clinical symptoms and supportive MR images findings [10]. The current study results 
show that the clinical effect of meniscectomy in relative young patients with traumatic meniscal 
tears and without significant knee OA is limited to better KOOS sports and recreation outcome 
scores. This effect is mainly present in patients who: (1) showed higher activity levels before the 
start of the knee complaints 10 years ago, (2) developed no ACL lesions during follow-up and (3) 
had no radiographic OA changes. The effect of a mean 19.2 points higher score in the KOOS 
Sport & Recreation scale seems to be of clinical relevance since 8-10 points is considered to be the 
minimal clinically important change [24].  
In the conservatively treated patient group, smaller traumatic meniscal tears were more often 
present compared to the patient group treated with meniscectomy (6 (13.6%) vs. 3 (1.6%)). This 
may be due to confounding by indication in the conservative group, since the general opinion is 
that meniscal tears smaller than 5mm are not clinically relevant and should be treated 
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conservatively [25]. However, the number of larger meniscal tears was not significant different 
between the conservatively treated group and the meniscectomy group (19 (43.2%) vs. 100 
(52.4%)) (Table 2). 
Several limitations of the current study should be mentioned. The large number of patients lost to 
follow-up, which may be partially due to the 10 year follow-up (529; 62%). Another limitation of 
the study was that only patients with persistent knee complaints might have been interested in 
participating in the follow up study, possibly biasing the results. To investigate this, all 87 subjects 
who refused participation were asked if they still had knee complaints. The majority of these 
subjects, 49 patients (56%), had knee complaints, but had other reasons not to participate in the 
study.  Traumatic tears were more often surgically treated in the follow-up group (77% vs. 64%, p-
value 0.014)). Another limitation is that the KOOS questionnaire was used at 10 years follow-up 
only, because it did not exist at baseline 10 years ago. There is a chance that baseline KOOS scores 
would have been different between the surgically and conservatively treated patient groups, 
however the baseline Tegner and Noyes scores were not different between these groups. Finally, at 
the start of the original cohort study, meniscal repair was not yet incorporated in common clinical 
practice, therefore we were not able to determine the clinical effects of meniscal repair in patients 
with traumatic meniscal tears. 
In conclusion, partial meniscectomy of traumatic meniscal tears in knee patients without locking 
complaints seem to result in better Sports and Recreation related long-term clinical outcomes. 
This effect is positively associated with higher activity levels before injury. Future randomized 
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Abstract 
In this study the contribution of the OA susceptibility genes ASPN,  GDF5, DIO2 and the 7q22 region 
to radiographic development of knee osteoarthritis (OA) in patients with a mean age of  40.6 years ± 
7.9 (SD) who suffered from non-acute knee complaints a decade earlier was examined. Dose response 
associations of  4 SNP’s on the susceptibility genes were determined by comparing 36  patients who 
showed development of OA on radiographs (Kellgren&Lawrence score 1) with 88 patients who had 
no development of OA on radiographs and normal cartilage. Multivariate logistic regression analysis 
including the variables age, gender, body mass index (BMI) and reported knee trauma was performed. 
A dose response association of DIO2 SNP rs225014: odds ratio (OR) 2.3, 95% CI 1.1-4.5 (P=0.019)  
and GDF5 SNP rs143383: (OR) 2.0, 95% CI 1.1-3.8 (P=0.031) was observed with knee OA 










Osteoarthritis (OA) of the knee is a common cause of musculoskeletal disability and is 
characterized by late-onset degeneration of articular cartilage, which is marked by the 
recapitulation of OA articular chondrocytes to a growth plate morphology and signalling and 
breakdown of matrix proteins1. This leads to the development of fibrillations, fissures and 
ulcerations at the articular cartilage surface most sensitively detected by magnetic resonance (MR) 
imaging 2. To detect common underlying pathways that affect susceptibility, large scale genetic 
studies have been performed and have revealed a considerable number of robust OA susceptibility 
gene products which appear to be active in a shared pathway involving the developmental process 
of endochondral ossification 3,4. The susceptibility genes ASPN 5,  GDF5 6, DIO2 3 and the 7q22 
locus 7 are considered consistent early OA susceptibility signals that have  shown  replication in 
several distinct studies for OA development 8 and additionally showed functional follow up data 
that provided insight into underlying disease mechanisms 9-11. Progression of disease could result 
in reactivation of genes involved in endochondral ossification, leading to loss and mineralization 
of articular cartilage, a process known to contribute to OA 3,12.  
The aim of this study is to examine the contribution of the risk alleles of ASPN,  GDF5, DIO2 and  
the top SNP of the 7q22 locus to radiographic development of knee OA in a relatively young study 
population that presented with non-acute knee symptoms a decade earlier by comparing patients 
with radiographic OA development and patients without signs of OA in the knee on radiographs 




Study design: Case-control, Level of Evidence: 3. The current study was approved by the Medical 
Ethics Review Boards and written informed consent of each participant was obtained. The current 
study is a follow-up of a trial performed 10 years ago. The initial study consisted of 856 patients 
(mean age 31 years ± 8.0 standard deviation (SD)) with non-acute knee complaints, defined as 
persistent knee complaints i.e. pain, swelling and instability, lasting more than four weeks 13. After 




14. To obtain DNA, all initial eligible 326 follow-up participants were contacted and sent a saliva 
collection container for DNA extraction. Eventually, 217 patients (67%) could be included. Of the 
109 lost subjects, 21 patients refused participation and 88 did not respond to the contact letter 
sent by mail, a second letter sent after 1 month and three contact attempts by telephone. MR 
images and radiographs of the initial symptomatic knee were taken at inclusion and after 10 years. 
The presence of on radiographs detectable OA features was compared between the baseline and 
follow-up images. None of the patients showed radiographic knee OA at baseline. Due to different 
scanning techniques and other scoring methods used at baseline and after 10 year follow-up, the 
MR outcomes from baseline and follow-up outcomes could not be compared accurately to assess 
OA development. Therefore, a certain degree of OA development in those patients without 
radiographic OA development but with cartilage defects visible on MR images could not be ruled 
out. In order to compare patients with radiographic OA development to a control group without 
any signs of OA development, only patients without cartilage defects visible on MR images were 






Figure 1  Flowchart response to follow-up 
INITIAL STUDY  
856 patients 
mean age 31 years ± 8; 33% Women 
5 died 
21 excluded 
87 refused participation 
10 year FOLLOW-UP STUDY 
326 patients eligible to participate 
33% Women 
 
21 refused DNA collection 
88 non-responders 
PRESENT STUDY 
DNA collected in 217 patients 
Mean age 42.1 years ± 8 
33% Women 
 
No radiographic OA development but  
cartilage defects present on MR images 
N=84 
Mean age 44.2 years ± 7.2 
29% Women 
No follow-up radiographs available  N=9 
Mean age 41.6 years ± 8.0; 22% Women 
OA DEVELOPMENT &  
CARTILAGE DEFECTS 
N=36 
Mean age 44.5 years ± 6.7 
31% Women 
NON-OA DEVELOPMENT &  
NO CARTILAGE DEFECTS 
N=88 
Mean age 39.1 years ± 7.9 
40% Women 
DIO2 rs225014 C allele frequency 
ASPN rs13301537 T allele frequency 
GDF5 rs143383 T allele frequency 




Radiographic knee examination and assessment 
Standardized weight bearing posterior-anterior knee radiographs next to supine lateral 
radiographs of the knee were made at baseline and at 10 year follow-up. At baseline one of six 
musculoskeletal radiologists with at least four years of experience scored the radiographs for 
overall severity of OA using the K&L system 15. The follow-up radiographs were scored by an 
experienced musculoskeletal radiologist and a research fellow using the same K&L scoring 
method 14. Individual development of OA was obtained by comparing the baseline K&L score to 
the follow-up K&L scores. Development of OA was considered to be present at a K&L score of 1 
point or more. 
 
Knee MRI 
MRI examinations after 10 years of the initial affected knee were performed on a 3 T system 
(Achieva 3T, Philips Medical Systems, Best, the Netherlands). Due to different MRI scanning 
techniques used at baseline and at 10 year follow-up, only the follow-up scans were used to assess 
cartilage defects. Focal cartilage defects were defined as an abrupt transition between the defect 
and surrounding cartilage, a diffuse cartilage defect was defined as a gradual transition between 




DNA from patients was obtained using saliva collecting containers (Oragene OG-250, DNA 
Genotek, Ontario, Canada). Recent studies have shown that the use of saliva samples is a good 
alternative to blood samples to obtain genomic DNA of high quality 17.  
The containers were sent to all 326 eligible patients including instructions for use. All patients 
were asked to wash their mouth once with water and to wait at least 30 seconds. Then, the 
patients were asked to spit in the white container, to cap the container with the blue lid, and 
finally to gently shake the sample. The Oragene saliva samples were stored according to 
manufacturer at room temperature until DNA extraction. On average saliva sampes were stored 




DNA was extracted from saliva samples using the Oragene kit (DNA Genotek) as described by the 
manufacturer. The Oragene saliva samples were incubated at 50°C for 2 hours. The 0.5 ml sam-
ples were transferred to a 1.5 mL Eppendorf tubes ; 20  L of Oragene purifier was added, and the 
sample was mixed by inversion and incubated on ice for 10 minutes. The samples were then cen-
trifuged in a small, bench top microfuge for 3 minutes at 18,000  g at room temperature and the 
supernatant was transferred to a new tube. 0.5 mL of 95% ethanol was added; the samples were 
mixed by inversion at least five times and incubated for 10 minutes at room temperature. The 
samples were then centrifuged in a small, bench top microfuge for 1 minute at 18,000g  at room 
temperature, the supernatants were discarded, and the DNA was dissolved in 100  L TE buffer 
(10 mmol/L Tris-HCl, 0.1 mmol/L EDTA (pH 8.0)) and quantified. The DNA samples were sto-
red at 4°C until PCR analysis. 
 
For the candidate gene association study we selected 4 SNPs on 4 candidate genes ASPN, GDF5, 
DIO2 and the 7q22 locus. These susceptibility genes have been shown to replicate in several dis-
tinct studies for primary OA 8. In the current study we hypothesize that these susceptibility genes 
already contribute to development of radiographic knee OA in relatively young  patients suffering 
from knee complaints. The P-values of Hardy-Weinberg test were for DIO2: 0.385, for GDF5: 
0.916, for ASPN: 0.033 and for the 7q22 locus: 0.242. All genotypes were included in the equation. 
Following is a description of the 4 candidate genes selected for the current study. 
 
DIO2 
Iodothyronine deiodinase enzyme type 2 (DIO2) is a regulator of thyroid hormone metabolism in 
the growth plate, where thyroid hormone triggers terminal maturation of growth plate 
chondrocytes 8. DIO2 has recently been shown to be a susceptibility gene for primary OA 3,18. In a 
genome-wide linkage scan and association analysis an association was found between OA and the 
minor C allele of SNP rs225014.3. We hypothesize that the DIO2 gene also contributes to 






Asporin (ASPN) inhibits transforming growth factor-  (TGF- ), which has a crucial role in the 
development and homeostasis of cartilage 19. ASPN is expressed at low levels in normal cartilage 
but is expressed abundantly in OA articular cartilage. Due to polymorphisms in the ASPN gene, 
variant ASPN proteins arise with a variable number of aspartic acid (D) repeats in the amino-
terminal end of the protein 20. The T allele of SNP (rs13301537) is associated with variants of the 
ASPN gene encoding 13 (D13) and 14 (D14) aspartic acid repeats 21. In a Japanese and Han 
Chinese population, but not in a Caucasian population, D14 was associated with knee OA and in 
a Caucasian population D13 was associated with a decreased risk of knee OA 21,22. 
 
GDF5 
Growth differentiation factor 5 (GDF5) is a bone morphogenetic protein (BMP) involved in early 
development of joints in embryonic tissues and is expressed throughout the synovial joint tissues 
during life 23. The SNP (rs143383) is the most widely replicated genetic association with knee OA, 
with the risk-associated T allele showing reduced expression relative to the C allele in OA 6.  The 
GDF5 rs143383 polymorphism is associated with knee OA in both Asians and Caucasians 6,24.  
 
7q22 locus 
Conserved oligomeric Golgi complex subunit 5 (COG5) was recently discovered in a genome-
wide association study as a novel gene involved in OA. The C allele of SNP (rs3815148) was 
associated with an increased risk of knee OA 7 .  
 
SNP genotyping 
Genotyping was carried out in 217 samples at OA susceptibility SNPs from 4 genes: ASPN, GDF5, 
DIO2  and the 7q22 locus. Selected SNPs were fit in a Sequenom multiplex assay designed by the 
Assay Designer software version 3.1 (Sequenom, San Diego, CA). SNPs were genotyped by mass 
spectrometry (the homogeneous MassARRAY system; Sequenom, San Diego, CA) using standard 
conditions. PCR reactions were carried out in a final volume of 5 µl and contained 2.5 ng of 
genomic DNA. Genotypes were assigned using Genotyper version 3.0 software (Sequenom, San 




were included, with a concordance rate of 100%. Genotype frequencies for the tested SNPs were 
all in Hardy-Weinberg equilibrium (Table 1). 
 
Statistical methods 
A case-control approach was also used to assess the association between the susceptible risk allele 
frequencies of the of the 7 selected SNP’s in patients with knee OA development and in patients 
without radiographic development of knee OA. Radiographic development of OA was defined a 
K&L score of  1. Patients who did not show radiographic OA development, but who did have 
cartilage defects detected on the follow-up MR images were excluded from further analysis (Figu-
re 1). A logistic regression model was fitted to measure the strength of the association with the 
different genotypes (dose response), which is expressed as odds ratios (OR) with 95% confidence 
intervals (95% CI). In these analyses we adjusted for age, gender, body mass index (BMI) and re-
ported knee trauma. P-values < 0.05 were considered to indicate statistical significance. In order 
to assess the discriminating power of the different genotypes studied, we generated receiving ope-
rator curves (ROC) using knee development as outcomes and age, sex, BMI and trauma as con-




Of the 124 patients included in the current study, 5 patients (4 %) were of non-Caucasian descent. 
At follow-up, the mean age of the 124 patients included for the association study was 40.6 years ± 
7.9 (SD), 46 (37.1%) of the patients were female and the average body mass index (BMI) was 25.6 
± 3.5 (SD).  
 
OA development 
Of the 36 patients who developed radiographic knee OA after 10 years follow-up 27 had a K&L 
score of  1, and 9 had a K&L score of 2. Of the 172 patients without radiographic development of 
OA, 84 (48.8%) showed cartilage defects detected on MR images, and 88 (51.2%) did not. The 




significant older and had significantly higher BMI’s than the controls without OA development 
and without cartilage lesions (Table 1).  
As shown in Table 1, the minor C allele frequency of the rs225014 SNP in the control group 
without OA development and without cartilage lesions was 0.341 whereas, in the study group 
with OA development the minor C allele frequency was 0.471. There was a significant association 
for the presence of the minor C allele of SNP rs225014 of the DIO2 gene and radiographic knee 
OA development (OR 1.8, 95% CI 1.00-3.18; P value 0.049). This effect increased when corrected 
for Age, BMI and Trauma (OR  2.3, 95% CI 1.14-4.49; P value 0.019). The GDF5 T-allele 
frequency of the rs143383 SNP was 0.366 in the control group without OA development and 
cartilage lesions and 0.444 in the OA development group. Corrected for Age, BMI and Trauma, 
there was a significant association for the presence of the T allele of SNP rs143383 of the GDF5 
gene and OA development (OR 2.0, 95% CI 1.07-3.78, P value 0.031). The OA susceptibility SNP 
in ASPN and at the 7q22 locus did not show association (Table 1). 
Finally, we investigated whether the genes associated to increasing aspects of joint destruction as 
measured by radiographs and/or MRI characteristics after 10 years as defined by subjects without 
radiographic OA nor cartilage lesions visible on MR images (N=88), no radiographic signs of OA  
but with cartilage defects visible on MR images (N=84), and radiographic OA with cartilage 
defects visible on MR images (N=36). DIO2 showed significant association (P Value 0.020) with 












defects   N = 88 
OA 
development  











Gender  35 (39.8%) 11 (30.6%) 0.67 0.29-1.53 0.336 0.75 0.28-2.01 0.561 
Age 39.1 ± 7.9 (SD) 44.5 ± 6.7 (SD) 1.10 1.04-1.17 0.001* 2.00 1.03-1.17 0.004* 
BMI 25.2 ± 3.6 (SD) 26.7 ± 2.7 (SD) 1.14 1.02-1.28 0.019* 1.10 0.96-1.27 0.162 
Trauma 54 (64.3%) 20 (60.6%) 0.86 0.37-1.96 0.710 1.18 0.46-3.05 0.733 
DIO2 rs225014 C allele 
frequency 
0.341 0.471 1.79 1.00-3.18 0.049* 2.27 1.15-4.49 0.019* 
ASPN rs13301537 T allele 
frequency 
0.244 0.300 1.19 0.65-2.18 0.575 1.20 0.53-2.7 0.659 
GDF5 rs143383 T allele 
frequency 
0.366 0.444 1.40 0.81-2.39 0.225 2.01 1.07-3.78 0.031* 
7q22 locus rs3815148           
C allele frequency 
0.241 0.264 1.15 0.60-2.20 0.684 1.13 0.51-2.52 0.760 







Multivariate regression analysis outcomes of OA development and cartilage lesions visible on MR imaging 
Variables 
No OA development & 
No Cartilage defects on 
MRI 
N = 88 
No OA development 
but Cartilage defects 
on MRI 
N = 88 
Radiographic OA 
development & Cartilage 
defects 
N = 36 
P-Value 
DIO2 rs225014 C allele frequency 0.341 0.409 0.471 0.020* 
ASPN rs13301537 T allele frequency 0.244 0.244 0.300 0.411 
GDF5 rs143383 T allele frequency 0.366 0.378 0.444 0.206 
7q22 locus rs3815148 C allele frequency 0.241 0.244 0.264 0.586 
OA = osteoarthritis, OR = Odds ratio, CI = Confidence Interval. Outcomes were corrected for Age, Sex, BMI and Trauma 









Increased risk prediction of DIO2 and GDF5 genotypes 
To investigate the possibility to use the DIO2 and GDF5 genotypes as a predictive tool, we next 
performed a receiver operating characteristics (ROC) analysis. Two models were fitted with knee 
OA development after a non-acute knee symptoms as the outcome. Model one consisted only of 
age, gender, BMI and trauma, model two included age, gender, BMI, trauma and DIO2 and GDF5 
genotypes. The predictive value of the anthropometric traits alone as reflected by the area under 
the curve (AUC) was 0.647 (95%CI 0.530-0.764), however, when genotypes of the DIO2 and 
GFD5 gene were added the AUC improved to 0.697 (95%CI 0.582-0.812) (Figure 2). 
 
Figure 2 
Receiver operating characteristics (ROC) analysis diagrams. The outcome is osteoarthritis (OA) 
development a decade after knee complaints. In Figure 2A the model included age, gender, trauma 













In Figure 2A the area under the curve (AUC) is 0.647 (95%CI 0.530-0.764). In Figure 2B the AUC is 






In the current study we showed that the DIO2 OA susceptibility SNP rs225014 and the GDF5 sus-
ceptibility rs143383 SNP are significantly associated with development of knee OA (OR 2.3; 95% 
CI 1.14-4.49 and OR 2.0; 95% CI 1.07-3.78, respectively) in a relatively young patient group with a 
mean age of 44 years with a history of knee complaints a decade ago. This effect appeared inde-
pendent of other factors related to knee OA development such as knee trauma, age and BMI. Pre-
diction of knee OA development improved from an average AUC of 0.647 for age, sex, BMI and 
trauma alone to an AUC of 0.697 when including DIO2 and GDF5 genotypes in the risk predicti-
on model, almost reaching clinical relevant AUC value (  0.7). Furthermore, an increased minor 
allele frequency of DIO2 is related to signs of OA development visible on both radiographs and 
MR images (P Value 0.020) and a similar trend is visible for GDF5, however, not significant (P 
Value 0.206). 
These data are in line with recently published data showing that articular cartilage expression of 
DIO2 is epigenetically regulated and that particularly DIO2 rs225014 risk allele carriers are less 
able to maintain cartilage homeostasis due to the fact that subtle changes in methylation, generally 
occurring upon environmental changes such as micro traumas, resulted in detrimental up-
regulation of DIO2 9. Type II deiodinase (D2), expressed by the DIO2 gene regulates the bio-
availability of intracellular T3 in specific tissues such as the growth plate and facilitates terminal 
maturation of hypertrophic chondrocytes. Functional genomic studies showed high expression of 
DIO2 mRNA and D2 protein levels in osteoarthritic as compared to healthy cartilage 18. Further-
more, DIO2 allelic imbalance was assessed and showed that the OA risk allele ‘C’ was more abun-
dantly present in articular joint tissues than the wild-type allele ‘T’ 18. Up regulation of DIO2 ex-
pression in a human in vitro model resulted in a marked reduction of the capacity of 
chondrocytes to deposit ECM components, including type II and type X collagen, while inducing 
OA-specific markers of cartilage matrix degeneration and mineralization 9. In mice undergoing a 
forced running regime it has been shown that DIO2 deficiency has a protective effect on the ho-




 It may be that trauma at relatively early age affects the the propensity of the highly specialized, 
maturational arrested articular chondrocytes to loose their maturational arrested state loss of epi-
genic control, among others, of the DIO2 gene.  
Our results show that the T allele of the GDF5 SNP rs143383 is significantly associated with deve-
lopment of knee OA with an OR of 2.0 (95% CI 1.07-3.78). This is in line with earlier findings that 
GDF5 rs143383 polymorphism is associated with knee OA in both Asians and Caucasians 6,24,26. 
Recent research showed that GDF5 stimulation of human chondrocytes inhibits expression of 
cartilage ECM degrading enzymes MMP13 and ADAMTS4 and stimulates the expression of 
cartilage anabolic genes ACAN and SOX9 27. GDF5 stimulation also inhibits the canonical Wnt 
signaling pathway through expression of the DKK1 and FRZB inhibitors. The Wnt signaling pa-
thway plays an important role during cartilage development, and activation of the pathway in the 
adult cartilage tissue leads to hypertrophy, initiation of calcification and tissue degradation via 
increased expression of ECM degrading components 27. Therefore altered expression of the GDF5 
gene may result in ECM degradation and decrease of cartilage quality which may induce OA 
development. 
It is commonly accepted that a clinically useful diagnostic markers should have an AUC of 0.7 or 
higher 28. Adding DIO2 and GDF5 genotypes in the model resulted in a significant increase of the 
AUC from 0.647 to 0.697. The latter underscores, that although patient characteristics and envi-
ronmental factors are important, genetic factors play a substantial role in knee OA development. 
Non of the investigated SNP’s of the ASPN,  and the 7q22 locus genes were significantly associated 
with OA development in the current study population. These findings are in line with outcomes 
of recent studies which report conflicting evidence about these genes in OA development 29,30 
In total  five patients patients of non-Caucasian descent were included in this study, however, 
upon discarding these patients, DIO2 and GDF5 outcomes remained the same, indicating that 
these patients did not drive our associations and possibly that these genes  confer risk to OA deve-
lopment in both Caucasian and non-Caucasian populations as previously shown.3,6,10,11,18,31,32 .  
Several limitations of the study should be mentioned. Due to different scanning techniques and 
other scoring methods used at baseline and after 10 year follow-up, the MR outcomes from base-




fore, a certain degree of development in those patients without radiographic OA but with cartilage 
defects visible on MR images could not be ruled out. In order to compare patients with radio-
graphic OA development to a control group without any signs of OA development, only patients 
without cartilage defects visible on MR images were used as controls. This restriction resulted in 
exclusion of 43% of the initial study group, leading to a significant smaller study population. Be-
ing aware of the tendency of association studies to produce false-positive results, additional repli-
cation is necessary. In the current study gender differences were not related to OA development. 
This may be explained by the fact that the female participants in the relatively young study popu-
lation were mostly pre-menopausal.  
In conclusion, the presence of the minor C-allele of the DIO2 SNP rs225014 and the T allele of the 
GDF5 SNP rs143383  are associated with OA development in a relatively young study population 
10 years after knee complaints. Subsequent ROC analyses showed that determining DIO2 and 
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Chapter 1 provides a general introduction. The main aim of this thesis is to determine which 
prognostic factors for knee OA development can be identified in a relatively young population with a 
history of knee complaints. Identifying these specific prognostic factors may help to distinguish high-
risk knee patients for the development of knee osteoarthritis (OA)  early in life. Additionally, we 
investigated the short-term and long-term clinical effects of surgical management of traumatic 
meniscal tears. 
 
In Chapter 2 we defined localized development of knee osteoarthritis OA that arises from anterior 
cruciate ligament (ACL) and meniscal injuries identified on 0.5T MR images performed a decade ago 
in patients with sub-acute knee symptoms. Also the effect of surgical management of these lesions on 
OA development was investigated. A follow-up study was performed in 326 patients (mean age 42 
years, 33% female) who were all part of a cohort of 855 knee patients who participated in a study on 
the cost-effectiveness of 0.5T magnetic resonance (MR) imaging relative to diagnostic arthroscopy. 
The mean follow-up was 10 years. Initial findings and differences in treatment were compared with 
follow-up radiographs and 3.0T MR scans. Odds ratios (OR) with 95%CI confidence intervals were 
used to identify effects between variables. 
Patients with ACL ruptures had an increased risk of developing joint space narrowing (JSN), 
cartilaginous defects, osteophytes, bone marrow lesions, and subchondral cysts medially or laterally 
(OR, 2.4–9.8). Patients with medial meniscal tears had an increased risk of  developing JSN, 
cartilaginous defects, osteophytes, and bone marrow lesions medially (OR, 2.0–15.3). Patients with 
lateral meniscal tears had an increased risk of developing JSN, cartilaginous defects, osteophytes, bone 
marrow lesions, and subchondral cysts laterally (OR, 2.1–10.5). Meniscectomy and ACL 
reconstruction had no effect on the risk of developing OA. 
We conclude that localized development of knee OA arises from ACL and meniscal lesions identified 
on MR images a decade earlier in patients with sub-acute knee symptoms and that surgical treatment 
of ACL and meniscal lesions have no effect on the development of OA.  
 
In Chapter 3 we validated a newly developed quantification method that automatically detects and 
quantifies the joint space width (JSW) in hand radiographs. Decrease of JSW is considered to be an 




and sensitivity to changes in JSW were determined and the influence of joint location and joint shape 
on the measurements was tested.  
A mechanical micrometer set-up was developed to define and adjust the true JSW in an acrylic 
phantom joint and in human cadaver-derived phalangeal joints. Radiographic measurements of the 
JSW were compared to the true JSW. Repeatability, systematic error (accuracy) and sensitivity (defined 
as the smallest detectable difference (SDD)) were determined. The influence of joint position on the 
JSW measurement was assessed by varying the location of the acrylic phantom on the X-ray detector 
with respect to the X-ray beam and the influence of joint shape was determined by using 
morphologically different human cadaver joints. 
The mean systematic error was 0.052 mm in the phantom joint and 0.210 mm in the cadaver 
experiment. In the phantom experiments, the repeatability was high (SDD = 0.028 mm), but differed 
slightly between joint locations (p = 0.046), and a change in JSW of 0.037 mm could be detected. 
Dependent of the joint shape in the cadaver hand, a change in JSW between 0.018 and 0.047 mm could 
be detected. 
 
The automatic quantification method is sensitive to small changes in JSW. Considering the published 
data of JSW decline in the normal and osteoarthritic population, the first signs of hand OA 
progression with this method can be detected within one or two years.  
 
In Chapter 4 we identified risk factors for knee osteoarthritis (OA) development in a young to middle-
aged population with sub-acute knee complaints in order to define high risk patients who may benefit 
from early preventive or future disease modifying therapies. The relationship between known OA risk 
factors from literature described in older study populations and OA development and knee function 
(Knee injury and Osteoarthritis Outcome Score (KOOS))  in 319 relatively young knee patients (mean 
age 41.5 years) was investigated. OA development visible on radiographs and MR images and KOOS 
knee function outcome scores 10 years after sub-acute knee complaints were assessed. Associations 
between OA development and age, gender, activity level (Tegner Scale), Body Mass Index (BMI), 
meniscal or ACL lesions, OA in first-degree relatives and radiographic hand OA were determined 
using multivariable logistic regression analysis. KOOS knee function outcomes were compared to 
normal population reference values and associations with age, gender, activity level, BMI, and ACL or 




OA on radiographs and MR in the tibiofemoral compartment (TFC) is associated with increased age 
(OR: 1.10, 95%CI 1.04-1.16 and OR: 1.07, 95%CI 1.02-1.13). TFC OA on radiographs only is 
associated with ACL and/or meniscal lesions (OR: 5.01, 95%CI 2.14-11.73), presence of hand OA (OR: 
4.69, 95%CI 1.35-16.32) and higher Tegner activity scores at baseline before the complaints (OR: 1.20, 
95%CI 1.01-1.43). The presence of OA in the TFC diagnosed only on MRI is associated with a family 
history of OA (OR: 2.44, 95%CI 1.18-5.06) and a higher BMI (OR: 1.13, 95%CI 1.04-1.23). OA in the 
patellofemoral compartment (PFC) diagnosed on both radiographs and MR is associated with an 
increased age (OR: 1.06, 95%CI 1.02-1.12 and OR: 1.05, 95%CI 1.00-1.09). PFC OA diagnosed on 
radiographs  only is associated with a higher BMI (OR: 1.12, 95%CI 1.02-1.22). The presence of OA in 
the PFC diagnosed on MR only is associated with the presence of hand OA (OR: 3.39, 95%CI 1.10-
10.50). Compared to normal reference values, the study population had significantly lower KOOS 
scores in all different subscales. Lower KOOS scores in all subscales were associated with an increased 
BMI (Effect size reaching from 0.024- 0.064). TFC OA according to the Delphi criteria was associated 
with lower outcomes in the subscales Sports and Recreation and Quality of life (Effect size 0.027 and 
0.021). The presence of JSN and osteophytes in the PFC was associated with lower Quality of life scores 
(Effect size 0.017). Higher Tegner Activity scores at baseline were associated with higher scores in the 
subscales Pain and Sports and recreation (Effect size 0.018 and 0.019). A higher age was associated 
with lower scores in the subscales ADL and Pain (Effect size 0.018 and 0.048). The presence of ACL 
and/or meniscal lesions was associated with lower Symptoms scores (Effect size 0.019). 
These results show that knee OA development in young to middle aged patients with a history of  sub-
acute knee complaints is associated with the presence of known risk factors for knee OA. OA is already 
visible on radiographs and MRI after 10 years. These high risk patients may benefit from adequate OA 
management early in life.   
 
In Chapter 5 we investigated the short-term and long-term clinical effects of surgical management of 
traumatic meniscal tears in knee patients without knee locking symptoms. A 10 year follow-up in 118 
patients with sub-acute knee complaints (mean age 32 years SD 7.8) was performed. Clinical outcome 
measures of surgically and conservatively treated patients were compared using the Noyes and KOOS 
knee questionnaires. 
There were no differences in short- and long-term Noyes scores and long-term cross-sectional KOOS 




significantly better in surgically treated patients (19.2 points, 95% CI 1.5; 36.8, p=0.033). Higher 
activity levels before the start of the complaints improved this effect.  
Therfore, partial meniscectomy of traumatic meniscal tears may result in better Sports and Recreation 
related long-term clinical outcomes. This effect is positively associated with higher activity levels 
before injury. Future randomized controlled trials may elucidate the effect of surgical treatment of 
traumatic meniscal tears. 
 
In Chapter 6 we examined the contribution of the OA susceptibility genes ASPN,  GDF5, DIO2 and 
the 7q22 region to radiographic development of knee osteoarthritis (OA) after 10 years in patients with 
knee complaints a decade earlier. 
A dose response association of  4 SNP’s on the susceptibility genes ASPN,  GDF5, DIO2 and the 7q22 
locus were determined by comparing 36  patients who showed development of OA on radiographs 
with 88 patients who had no development of OA on radiographs and normal cartilage on MRI. OA 
development was defined as a Kellgren and Lawrence (K&L) score 1. Multivariate logistic regression 
analysis including the variables age, gender, body mass index (BMI) and reported knee trauma was 
performed to determine associations between OA development and the presence of the risk alleles. 
A dose response association of DIO2 SNP rs225014: odds ratio (OR) 2.3, 95% CI 1.1-4.5 (P=0.019)  
and GDF5 SNP rs143383: (OR) 2.0, 95% CI 1.1-3.8 (P=0.031) was observed with knee OA 
development. The ASPN and 7q22 SNPs  were not associated with OA development.. 
We conclude that the presence of the risk alleles of  the DIO2 SNP rs225014 and the  the GDF5 SNP 
rs143383 are associated with OA development in a relatively young study population 10 years after 
knee complaints. Determining DIO2 and GDF5 genotypes significantly improves risk prediction 
towards clinical relevant values. 
 
General Conclusion 
In this thesis we demonstrated that several known risk factors for knee OA development i.e. ACL 
ruptures, meniscal tears, the presence of hand OA and increased BMI, are already associated with knee 
OA development as demonstrated on radiographs and MR images early in life. Identifying these 
factors in young to middle aged patients suffering from knee complaints helps to define high risk 
patients who may benefit from early preventive exercise therapy or maybe disease modifying drugs 




Meniscectomy and ACL reconstruction have no effect on knee OA development after 10 years in 
patients with sub-acute knee complaints.  
The in this thesis validated automatic JSW quantification method is sensitive to small changes in JSW 
of the finger joints. The first signs of hand OA development with this method can be detected within 
one or two years.  
In patients with traumatic meniscal tears but without knee locking symptoms, there may be some 
benefits from treatment with meniscectomy in long-term Sports and Recreation knee function 
outcomes compared to conservative treatment. Future randomized controlled trials may elucidate the 








Hoofdstuk 1 is een algemene introductie van dit proefschrift. Het belangrijkste doel van het promo-
tieonderzoek is om te bepalen welke prognostische factoren voor de ontwikkeling van knieartrose 
kunnen worden geïdentificeerd in een relatief jonge groep kniepatiënten. Het vaststellen van deze spe-
cifieke prognostische factoren zou kunnen bijdragen aan het vroegtijdig identificeren van hoogrisico 
patiënten met betrekking tot de ontwikkeling van knieartrose. Daarnaast onderzochten we de effecten 
van chirurgische behandeling van traumatische meniscusletsels op de kniefunctie op korte termijn en 
lange termijn. 
 
In Hoofdstuk 2 wordt beschreven hoe knieartrose zich volgens specifieke patronen  ontwikkelt bij 
patiënten met subacute knie klachten en voorste kruisband (VKB) en/of meniscusletsel, zichtbaar op 
0.5T magnetische resonantie (MR) beelden 10 jaar eerder. Ook het effect van chirurgische behande-
ling van dit letsel op artrose ontwikkeling werd onderzocht. Er werd een follow-up studie uitgevoerd 
bij 326 patiënten (gemiddelde leeftijd 42 jaar, 33% vrouwen) die deel uit maakten van een cohort van 
855 kniepatiënten welke participeerden in een studie naar de kosteneffectiviteit van 0.5T MR ten op-
zichte van diagnostische artroscopie, uitgevoerd 10 jaar geleden. De gemiddelde follow-up tijd was 10 
jaar. Uitkomsten van letsel op bij aanvang van de studie en de verschillende behandelingmethoden 
werden vergeleken middels follow-up röntgenfoto's en 3.0T MRI-scans. Odds ratio’s (OR) met 95%CI 
betrouwbaarheidsintervallen werden gebruikt om de effecten tussen de variabelen te bepalen. 
Patiënten met VKB letsel hadden een verhoogd risico op het ontwikkelen van gewrichtspleet vernau-
wing, kraakbeen defecten, osteofyten, beenmerglaesies, en subchondrale cysten mediaal of lateraal 
(OR, 2,4-9,8). Patiënten met mediale meniscus scheuren hadden een verhoogd risico op het ontwikke-
len gewrichtspleet vernauwing, kraakbeen defecten, osteofyten en beenmerglaesies mediaal (OR, 2,0-
15,3). Patiënten met laterale meniscus scheuren hadden een verhoogd risico op het ontwikkelen van 
gewrichtspleet vernauwing, kraakbeen defecten, osteofyten, beenmerglaesies en subchondrale cysten 
lateraal (OR, 2,1-10,5). Meniscectomie en VKB reconstructie hadden geen effect op het risico van het 
ontwikkelen van knieartrose. 
Wij concluderen dat knieartrose zich volgens specifieke patronen ontwikkeld gerelateerd aan  VKB en 
meniscus laesies geïdentificeerd op MR beelden tien jaar geleden bij patiënten met subacute knie 
symptomen. Chirurgische behandeling van VKB en meniscus laesies hebben geen effect op de ont-
wikkeling van artrose. 
In Hoofdstuk 3 wordt de validatie van een nieuw ontwikkelde kwantificatie methode die automatisch 





van de hand bepaald. Afname van de grootte van de gewrichtsspleet wordt gezien als een belangrijke 
maat voor de afname van kraakbeen, één van de belangrijkste kenmerken van artrose. Reproduceer-
baarheid, nauwkeurigheid en gevoeligheid voor veranderingen van de grootte van de gewrichtsspleet 
werden bepaald en de invloed van plaatsing van het gewricht ten opzichte van de röntgenbuis en de 
vorm van het gewricht op de metingen werd getest. 
Een mechanische micrometer set-up werd ontwikkeld om de werkelijke grootte van de gewrichts-
spleet te definiëren en aan te passen in een plexiglas fantoomgewricht en in humane vingergewrichten 
verkregen middels dissectie. Automatische röntgenmetingen van de grootte van de gewrichtsspleet 
werden vergeleken met de werkelijke grootte van de gewrichtsspleet. Reproduceerbaarheid, systemati-
sche fout (nauwkeurigheid) en gevoeligheid voor veranderingen (gedefinieerd als de kleinste detec-
teerbare verschil (Smallest Detectable Difference = SDD)) werden bepaald. De invloed van de positie 
ten opzichte van de röntgenbuis op de grootte van de gewrichtsspleet meting werd bepaald door het 
variëren van de locatie van het plexiglas fantoomgewricht op de detectorplaat ten opzichte van de 
röntgenbundel. De invloed van de verschillende gewrichtsvormen werd bepaald door de uitkomsten 
van de morfologisch verschillende humane kadaver gewrichten te vergelijken. 
De gemiddelde systematische fout was 0,052 mm in het fantoomgewricht en 0,210 mm in het kadaver 
experiment. In de fantoom experimenten was de reproduceerbaarheid hoog (SDD = 0,028 mm), maar 
deze was enigszins verschillend afhankelijk van de lokalisatie ten opzichte van de röntgenbundel (p = 
0,046). Een verandering van de grootte van de gewrichtsspleet van 0.037 mm kon betrouwbaar wor-
den bepaalld. Afhankelijk van de vorm van de humane kadaver gewrichten kon een verandering van 
de grootte van de gewrichtsspleet tussen de 0,018 en 0,047 mm betrouwbaar worden bepaald. 
De automatische kwantificatie methode is gevoelig is voor kleine veranderingen in de grootte van de 
gewrichtsspleet. Gezien de gegevens verkregen uit de literatuur met betrekking tot de gewrichtsspleet 
afname in de normale populatie en in patiënten met handartrose, kunnen de eerste tekenen van hand-
artrose progressie met deze methode worden gedetecteerd binnen één of twee jaar. 
 
In Hoofdstuk 4 worden risicofactoren voor knieartrose ontwikkeling in een relatief jonge groep pati-
enten met subacute knieklachten bepaald om hoogrisico patiënten te kunnen identificeren welke zou-
den kunnen profiteren van de vroege preventieve of in de toekomst te ontwikkelen medicamenteuze 
therapieën. De relatie tussen artrose risicofactoren bekend uit onderzoek bij oudere onderzoekspopu-





middelde leeftijd 41,5 jaar). Artrose ontwikkeling na 10 jaar werd vastgesteld op röntgenfoto's en MR-
beelden. Tevens werden subjectieve kniefunctie uitkomstscores (KOOS vragenlijst) 10 jaar na de sub-
acute knieklachten bepaald. Associaties tussen artrose ontwikkeling en leeftijd, geslacht, activiteiten-
niveau (Tegner vragenlijst), Body Mass index (BMI), meniscus of ACL-laesies, artrose in de eerste-
graads familieleden en handartrose zichtbaar op röntgenfoto’s werden bepaald met behulp van 
multivariabele logistische regressie-analyse. KOOS kniefunctie uitkomsten werden vergeleken met de 
normale referentiepopulatie waarden en associaties met artrose ontwikkeling, leeftijd, geslacht, activi-
teitenniveau, BMI, en ACL of meniscus letsels werden bepaald met een MANCOVA analyse. 
Artrose zichtbaar op röntgenfoto’s en MR beelden in het tibiofemorale compartiment (TFC) is geas-
socieerd met hogere leeftijd (OR: 1.10, 95%CI 1,04-1,16 en OR: 1.07, 95%CI 1,02-1,13). TFC artrose 
zichtbaar op röntgenfoto’s is geassocieerd met VKB en / of meniscus letsel (OR: 5,01, 95%CI 2,14-
11,73), de aanwezigheid van handartrose (OR: 4,69, 95%CI 1,35-16,32) en hogere Tegner activiteit 
scores voordat het klachten begonnen (OR: 1,20, 95%CI 1,01-1,43). De aanwezigheid van artrose in 
het TFC zichtbaar op MR beelden is geassocieerd met het voorkomen van artrose in eerstegraads fa-
milieleden (OR: 2.44, 95%CI 1,18-5,06) en een hogere BMI (OR: 1.13, 95%CI 1,04-1,23). ARTROSE in 
het patellofemorale compartiment (PFC) zowel zichtbaar op röntgenopnamen en MR beelden is geas-
socieerd met een hogere leeftijd (OR: 1,06, 95%CI 1,02-1,12 en OR: 1.05, 95%CI 1,00-1,09). PFC artro-
se zichtbaar op alleen röntgenopnamen is geassocieerd met een hoger BMI (OR: 1.12, 95%CI 1,02-
1,22). De aanwezigheid van artrose in het PFC gediagnosticeerd op MR beelden is geassocieerd met de 
aanwezigheid van handartrose (OR: 3.39, 95%CI 1,10-10,50). In vergelijking met de normale referen-
tiewaarden, hadden de onderzoekspopulatie significant lagere KOOS scores in alle verschillende sub-
schalen. Lagere KOOS scores in alle subschalen was geassocieerd met een verhoogd BMI (Effectgroot-
te 0.024- 0.064). TFC artrose zichtbaar op MR beelden was geassocieerd met een lagere scores in de 
KOOS subschalen Sport en Recreatie en Kwaliteit van leven (Effectgrootte 0,027 en 0,021). De aanwe-
zigheid van gewrichtspleet vernauwing en osteofyten in het PFC was geassocieerd met een lagere kwa-
liteit van leven score (Effectgrootte 0,017). Hogere Tegner activiteiten scores voordat de knieklachten 
begonnen waren geassocieerd met hogere scores in de subschalen Pijn en Sport en Recreatie (Effect-
grootte 0,018 en 0,019). Een hogere leeftijd werd geassocieerd met lagere scores in de subschalen ADL 
en Pijn (Effect grootte 0,018 en 0,048). De aanwezigheid van ACL en / of meniscus letsels werd geas-





Deze resultaten laten zien dat knieartrose bij jonge tot middelbare patiënten met een voorgeschiedenis 
van subacute knieklachten geassocieerd is met de aanwezigheid van bekende risicofactoren voor het 
ontwikkelen van knieartrose. Knieartrose ontwikkeling is in deze relatief jonge groep kniepatiënten 
reeds na 10 jaar zichtbaar zijn op röntgenfoto's en MR beelden. Het lijkt waarschijnlijk dat deze hoog-
risico patiënten baat hebben bij een vroege, adequate artrose behandeling. 
 
In hoofdstuk 5 onderzochten we de klinische korte termijn en lange termijn effecten van chirurgische 
behandeling van traumatisch meniscusletsels in de kniepatiënten zonder slotklachten. Een 10 jaar fol-
low-up studie bij 118 patiënten met subacute knieklachten (gemiddelde leeftijd 32 jaar, SD 7.8) werd 
uitgevoerd. Klinische uitkomstmaten van operatief en conservatief behandelde patiënten werden ver-
geleken met behulp van de Noyes en KOOS knie vragenlijsten. 
Er waren geen verschillen in korte en lange termijn Noyes Score uitkomsten en langdurige cross-
sectionele KOOS Pijn, Symptomen, ADL en Kwaliteit van Leven resultaten . De KOOS Sport en Re-
creatie resultaten waren significant beter in de chirurgisch behandelde patiënten (19,2 punten , 95 % 
CI 1,5 ; 36,8  p = 0,033 ) . Een hoger activiteitenniveau voor aanvang van de klachten was positief geas-
socieerd met dit effect. Uit deze resultaten blijkt dat partiële meniscectomie van traumatische menis-
cus scheuren lijkt te leiden tot een betere Sport en Recreatie gerelateerde functionele lange termijn 
resultaten . Dit effect is positief geassocieerd met een hoger activiteitenniveau voor het letsel. Toekom-
stige gerandomiseerde gecontroleerde studies zouden het effect van chirurgische behandeling van 
traumatische meniscusletsels verder kunnen ophelderen. 
 
In hoofdstuk 6 onderzochten we de invloed van de aanwezigheid van de risico allelen van ASPN,  
GDF5, DIO2 and de 7q22 regio op ontwikkeling van knieartrose zichtbaar op röntgenfoto’s bij patiën-
ten met knieklachten 10 jaar eerder. 
Een dosis respons associatie van de verschillende genotypen werd bepaald bij 36 patiënten met radio-
logische knieartrose en 88 patiënten zonder knieartrose en zonder kraakbeenletsels zichtbaar op MR 
beelden. Artrose werd gedefinieerd als een Kellgren en Lawrence (K & L) score  1. Multivariate logis-
tische regressie-analyse met de variabelen leeftijd, geslacht, BMI en gerapporteerd knie trauma werd 
verricht om de associatie tussen artrose ontwikkeling bij dragers van de risico allelen van ASPN,  





De uitkomsten van de logistische regressie-analyse laten zien dat er een dosis respons associatie van 
het risico C-allel van de DIO2 SNP rs225014: odds ratio (OR) 2.3, 95% CI 1.1-4.5 (P=0.019)  en GDF5 
SNP rs143383: (OR) 2.0, 95% CI 1.1-3.8 (P=0.031) met knieartrose ontwikkeling bestaat (OR) 2.3, 
95%CI CI 1,14-4,49 en (p = 0,019). Receiver operating characteristics (ROC) analyse toonde een ver-
betering van de voorspelling van knieartrose ontwikkeling met een gemiddelde ‘area under the curve’ 
(AUC) van 0,647 bij in achtneming van leeftijd, geslacht, BMI en trauma tot een AUC van 0,697 wan-
neer tevens DIO2 en GDF5 genotypen als variabelen werden meegenomen in de analyse. 
Wij concluderen dat DIO2 en GDF5 artrose risico genotypen zijn geassocieerd met knieartrose ont-
wikkeling bij patiënten met knieklachten 10 jaar eerder. Het bepalen van  DIO2 en GDF5 genotypen 
verbetert de risicovoorspelling van knieartrose ontwikkeling tot klinische relevante waarden. 
 
Algemene conclusies 
Verschillende risicofactoren voor het ontwikkelen van knieartrose zichtbaar op röntgenfoto’s en MR 
beelden kunnen relatief vroeg in het leven worden bepaald.  Belangrijke risicofactoren zijn o.a. de 
aanwezigheid van VKB rupturen, meniscus scheuren, handartrose en een verhoogd BMI. Daarnaast  
speelt genetische aanleg een rol bij ontwikkeling van knieartrose. Het bepalen van deze risicofactoren 
helpt bij het identificeren van hoogrisico patiënten die kunnen profiteren van vroege preventieve of 
toekomstige, nog te ontwikkelen medicamenteuze therapieën. 
De in dit proefschrift besproken gevalideerde automatische kwantificatie methode van gewrichtssple-
ten in vingergewrichten is in staat om betrouwbaar kleine veranderingen in de grootte van de ge-
wrichtsspleet te bepalen. De eerste tekenen van handartrose progressie kunnen met deze methode 
worden waargenomen binnen één of twee jaar. 
Behandeling van VKB en meniscusletsel door middel van VKB reconstructie en meniscectomie heb-
ben geen effect op knieartrose ontwikkeling na 10 jaar in patiënten met subacute knieklachten en VKB 
rupturen of meniscusscheuren.  
Bij patiënten met traumatisch meniscusletsel maar zonder slotklachten lijkt er, naast mogelijk enigs-
zins beter functioneren op sportniveau, geen duidelijk positief klinisch effect te bestaan van de behan-
deling met meniscectomie ten opzichte van conservatieve behandeling. Gerandomiseerd onderzoek 
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